SGC7901 |
Growth Inhibition Assay |
10 μM |
72 h |
DMSO |
GI50=0.55 μM |
24686011 |
HLF |
Growth Inhibition Assay |
10 μM |
72 h |
DMSO |
GI50=0.33 μM |
24686011 |
16HBE |
Growth Inhibition Assay |
10 μM |
72 h |
DMSO |
GI50=0.18 μM |
24650643 |
BALB/3T3 |
Growth Inhibition Assay |
|
|
|
IC50=0.5 μM |
24631190 |
26-L5 |
Function Assay |
|
6 h |
|
Antiinvasive activity |
24592993 |
CEM/ADR5000 |
Cytotoxic Assay |
|
|
DMSO |
Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein with IC50 of 23.27 μM |
24561670 |
CCRF-CEM |
Cytotoxic Assay |
|
|
DMSO |
IC50=0.009 μM |
24561670 |
V79 |
Cytotoxic Assay |
1.10 μM |
72 h |
DMSO |
IC50=0.24 μM |
24530030 |
MX1 |
Cytotoxic Assay |
1.10 μM |
72 h |
DMSO |
IC50=0.5 μM |
24530030 |
L929 |
Cytotoxic Assay |
1.10 μM |
72 h |
DMSO |
IC50=0.16 μM |
24530030 |
ME180 |
Cytotoxic Assay |
|
48 h |
|
IC50=0.39 μM |
24487188 |
MGC803 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.17 μM |
24370114 |
CHP100 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.79 μM |
24251417 |
Bel7402 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.5782 μM |
24211639 |
SGC7901 |
Cytotoxic Assay |
|
|
|
IC50=0.011 μM |
24195466 |
MKN28 |
Growth Inhibition Assay |
|
48 h |
|
GI50=0.24 μM |
24184076 |
Caco2 |
Growth Inhibition Assay |
|
48 h |
|
GI50=0.32 μM |
24184076 |
MDA-MB-468 |
Growth Inhibition Assay |
10 μM |
72 h |
|
GI50=0.085 μM |
24163729 |
Caco2 |
Cytotoxic Assay |
40 μM |
24 h |
|
Cytotoxicity |
24099994 |
U2OS |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.3 μM |
24095089 |
OVCAR8 |
Growth Inhibition Assay |
20 μM |
72 h |
|
Antiproliferative activity |
24095089 |
LNcaP |
Function Assay |
3 μM |
24 h |
|
Up-regulation of p53 expression |
24095089 |
LNcaP |
Function Assay |
3 μM |
24 h |
|
Increase of cleaved caspase-9 level |
24095089 |
Caov3 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.1 μM |
24095089 |
AS49-RAW |
Cytotoxic Assay |
100 μM |
48 h |
|
IC50=32.78 μM |
24077528 |
MDA-MB-435 |
Cytotoxic Assay |
100 μM |
48 h |
|
IC50=0.15 μM |
24028446 |
HUVEC |
Function Assay |
5 μM |
2 h |
|
Cellular uptake |
24028446 |
MRC5 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.1 μM |
24021462 |
HepG2 |
Function Assay |
40 μg/mL |
48 h |
DMSO |
Inhibition of TRK with IC50 of 0.0025 μM |
24013411 |
HUVEC |
Cytotoxic Assay |
|
48 h |
|
IC50=0.0807 μM |
24012378 |
KB/HeLa |
Cytotoxic Assay |
|
45 h |
|
EC50=0.25 μM |
23988351 |
MDA-MB-231 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intramitochondrial ROS level |
23973213 |
MDA-MB-231 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intracellular malonyldialdehyde level |
23973213 |
MDA-MB-231 |
Function Assay |
5 μM |
24 h |
|
Cellular uptake |
23973213 |
MCF7 |
Function Assay |
5 μM |
24 h |
|
Cellular uptake |
23973213 |
MCF7 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intracellular malonyldialdehyde level |
23973213 |
MCF7 |
Function Assay |
5 μM |
24 h |
|
Cellular uptake |
23973213 |
MCF7 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intramitochondrial ROS level |
23973213 |
H9c2 |
Function Assay |
5 μM |
24 h |
|
Cellular uptake |
23973213 |
H9c2 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intracellular ROS level |
23973213 |
H9c2 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intracellular malonyldialdehyde level |
23973213 |
H9c2 |
Function Assay |
5 μM |
24 h |
|
Antioxidant activity assessed as intramitochondrial ROS level |
23973213 |
HaCaT |
Growth Inhibition Assay |
25 μg/mL |
48 h |
|
TGI50=0.4 μM |
23876338 |
UO31 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.49 μM |
23871905 |
UACC257 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.14 μM |
23871905 |
U251 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.04 μM |
23871905 |
TK10 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.18 μM |
23871905 |
SR |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.03 μM |
23871905 |
SNB75 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.07 μM |
23871905 |
SNB19 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.04 μM |
23871905 |
SN12C |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.07 μM |
23871905 |
SK-MEL-28 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.21 μM |
23871905 |
SF539 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.12 μM |
23871905 |
RXF393 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.1 μM |
23871905 |
PRMI8226 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.08 μM |
23871905 |
OVCAR-8 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.1 μM |
23871905 |
OVCAR5 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.41 μM |
23871905 |
OVCAR4 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.37 μM |
23871905 |
NCI-H522 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.03 μM |
23871905 |
NCI-H322M |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.54 μM |
23871905 |
NCI-H226 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.05 μM |
23871905 |
MALME-3M |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.12 μM |
23871905 |
M14 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.18 μM |
23871905 |
LOXIMVI |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.07 μM |
23871905 |
KM12 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.27 μM |
23871905 |
IGROVI |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.17 μM |
23871905 |
HOP92 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.1 μM |
23871905 |
HCC2998 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.26 μM |
23871905 |
EKVX |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.41 μM |
23871905 |
Caki1 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.95 μM |
23871905 |
ACHN |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.08 μM |
23871905 |
786-0 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.13 μM |
23871905 |
HOP62 |
Growth Inhibition Assay |
100 μM |
48 h |
|
GI50=0.14 μM |
23849207 |
Gurav |
Growth Inhibition Assay |
100 μM |
48 h |
|
GI50=0.17 μM |
23849207 |
DWD |
Growth Inhibition Assay |
100 μM |
48 h |
|
GI50=0.1 μM |
23849207 |
COLO205 |
Growth Inhibition Assay |
100 μM |
48 h |
|
GI50=0.14 μM |
23849207 |
LS180 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.04 μM |
23827179 |
786 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.33 μM |
23810282 |
HGF |
Cytotoxic Assay |
25 mM |
24 h |
|
IC50=0.5 μM |
23802716 |
C643 |
Cytotoxic Assay |
25 mM |
24 h |
|
IC50=0.07 μM |
23802716 |
B16F10 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.072 μM |
23777898 |
JURKAT-TALL |
Cytotoxic Assay |
|
48 h |
|
IC50=0.0096 μM |
23673218 |
U266 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.67 μM |
23600925 |
SW872 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.14 μM |
23600925 |
SK-UT-1 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.076 μM |
23600925 |
SK-ES-1 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.042 μM |
23600925 |
SK-BR-3 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.09 μM |
23600925 |
NCI-H929 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.065 μM |
23600925 |
MNNG-HOS |
Cytotoxic Assay |
|
72 h |
|
IC50=0.59 μM |
23600925 |
MDA-MB-436 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.1 μM |
23600925 |
A673 |
Apoptosis Assay |
|
24 h |
DMSO |
Induction of apoptosis assessed as caspase-3 activation with EC50 of 0.39 μM |
23600925 |
A673 |
Cytotoxic Assay |
|
72 h |
|
Cytotoxicity against human A673 cells after 72 hrs by resazurin/resorufin-based fluorescence assay with IC50 of 0.17 μM |
23600925 |
MA9.3 |
Cytotoxic Assay |
100 μM |
48 h |
|
IC50=0.086 μM |
23578690 |
SK-MEL |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=1.5 μM |
23547843 |
HeLa |
Cytotoxic Assay |
1 μM |
72 h |
|
IC50=0.01 μM |
23470139 |
POS1 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.043 μM |
23360521 |
OSRGA |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.093 μM |
23360521 |
L929 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.161 μM |
23360521 |
AT6-1 |
Growth Inhibition Assay |
|
72 h |
|
IC50=2 μM |
23360521 |
WHCO1 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.5 μM |
23353747 |
MOLT4 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.02 μM |
23218718 |
MGC803 |
Growth Inhibition Assay |
20 μM |
72 h |
DMSO |
IC50=0.7 μM |
23124210 |
Bcap37 |
Growth Inhibition Assay |
20 μM |
72 h |
DMSO |
IC50=1.28 μM |
23124210 |
HL60/Vinc |
Cytotoxic Assay |
100 μg/mL |
72 h |
DMSO |
Cytotoxicity against human HL60/Vinc cells with IC50 of 0.91 μM |
23079523 |
BALB/3T3 |
Cytotoxic Assay |
100 μg/mL |
72 h |
DMSO |
IC50=1.91 μM |
23079523 |
MG63 |
Cytotoxic Assay |
|
|
|
IC50=2.7 μM |
23043498 |
HL60/A |
Cytotoxic Assay |
|
18 h |
|
IC50=6.7 μM |
22985027 |
A549 |
Cytotoxic Assay |
|
|
|
IC50=0.001 μM |
22951040 |
MESSA/DX5 |
Growth Inhibition Assay |
100 μg/mL |
72 h |
DMSO |
IC50=0.25 μM |
22944121 |
SKLU1 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.0067 μM |
22858298 |
HCT15 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.005 μM |
22858298 |
U2OS |
Cytotoxic Assay |
4 μM |
72 h |
DMSO |
IC50=3.4 μM |
22749279 |
B16 |
|
|
48 h |
|
IC50=0.03 μM |
22668451 |
MKN45 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.168 μM |
22647723 |
HMEC1 |
Cytotoxic Assay |
250 μg/mL |
72 h |
|
IC50=0.06 μM |
22616554 |
BMDM |
Cytotoxic Assay |
250 μg/mL |
72 h |
|
IC50=4.6 μM |
22616554 |
J774A.1 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.02 μM |
22608675 |
WI38 |
Growth Inhibition Assay |
100 μM |
72 h |
DMSO |
IC50=0.04 μM |
22555152 |
SW620 |
Growth Inhibition Assay |
100 μM |
72 h |
DMSO |
IC50=0.04 μM |
22555152 |
NCI/ADR |
Growth Inhibition Assay |
25 μg/mL |
48 h |
|
IC50=13.5 μM |
22537680 |
786-0 |
Growth Inhibition Assay |
25 μg/mL |
48 h |
|
IC50=2.1 μM |
22537680 |
SMMC7721 |
Cytotoxic Assay |
500 μM |
48 h |
DMSO |
IC50=0.37 μM |
22537362 |
KB/VCR |
Cytotoxic Assay |
500 μM |
48 h |
DMSO |
IC50=0.45 μM |
22537362 |
U87MG |
Growth Inhibition Assay |
2 μM |
48 h |
|
IC50=0.79 μM |
22515366 |
NCI-H290 |
Growth Inhibition Assay |
2 μM |
48 h |
|
IC50=0.32 μM |
22515366 |
LLC |
Growth Inhibition Assay |
|
48 h |
|
IC50=0.207 μM |
22515366 |
XF498 |
Cytotoxic Assay |
|
48 h |
|
IC50=0.015 μM |
22483395 |
SK-MEL-2 |
Cytotoxic Assay |
|
48 h |
|
IC50=0.002 μM |
22483395 |
K562/A02 |
Growth Inhibition Assay |
|
72 h |
DMSO |
Antiproliferative activity against multidrug-resistant human K562/A02 cells overexpressing p-glycoprotein with IC50 of 46.69 μM |
22450134 |
HuH7 |
Growth Inhibition Assay |
25 ng/mL |
72 h |
DMSO |
Antiproliferative activity assessed as inhibition of BrdU incorporation |
22409771 |
HuH7 |
Function Assay |
25 ng/mL |
72 h |
DMSO |
Induction of senescence assessed as increase in senescence associated beta-galactosidase activity |
22409771 |
SK-N-SH |
Cytotoxic Assay |
|
48 h |
|
IC50=0.97 μM |
22386528 |
SiHa |
Growth Inhibition Assay |
|
|
|
GI50=0.14 μM |
22361684 |
B16 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.1 μM |
22330634 |
SKOV3 |
Function Assay |
5 μM |
1 h |
DMSO |
Cellular uptake in doxorubicin-resistant human SKOV3 cells |
22276998 |
SKOV3 |
Function Assay |
5 μM |
1 h |
DMSO |
Drug uptake in doxorubicin-resistant human SKOV3 cell nucleu |
22276998 |
LNcaP |
Apoptosis Assay |
20 μg/mL |
24 h |
water |
Induction of apoptosis assessed as increase in caspase 3/7 activation |
22264758 |
PC3M |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.24 μM |
22264149 |
QGY7701 |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=8.65 μM |
22182926 |
A375-C5 |
Growth Inhibition Assay |
|
48 h |
DMSO |
GI50=0.0915 μM |
22177409 |
RAW264.7 |
Cytotoxic Assay |
10 μM |
24 h |
DMSO |
Cytotoxicity assessed as cell viability |
22129061 |
SKOV3 |
Growth Inhibition Assay |
50 μM |
72 h |
DMSO |
Antiproliferative activity against human SKOV3 cells overexpressing c-Src |
22119472 |
BGC823 |
Cytotoxic Assay |
|
96 h |
DMSO |
IC50=0.98 μM |
22070654 |
HCT8 |
Cytotoxic Assay |
5 μg/mL |
72 h |
DMSO |
IC50=0.02 μM |
22000949 |
MCF7 |
Function Assay |
50 μg/mL |
48 h |
DMSO |
Reduction in AP-2 gamma mRNA expression |
22000946 |
MCF7 |
Function Assay |
50 μg/mL |
48 h |
DMSO |
Reduction in CYP19 mRNA expression |
22000946 |
MCF7 |
Function Assay |
50 μg/mL |
48 h |
DMSO |
Reduction in VEGF mRNA expression |
22000946 |
Neuro2a |
Cytotoxic Assay |
|
72 h |
|
IC50=1.2 μM |
21996519 |
PC3 |
Growth Inhibition Assay |
|
48 h |
|
GI50=0.09 μM |
21875046 |
AGS |
Growth Inhibition Assay |
|
48 h |
|
GI50=0.01 μM |
21875046 |
BT20 |
Growth Inhibition Assay |
10 μM |
72 h |
|
Antiproliferative activity |
21852023 |
K562/A02 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=17.84 μM |
21843940 |
Ca9-22 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.26 μM |
21800859 |
SH-SY5Y |
Cytotoxic Assay |
|
48 h |
|
IC50=0.5 μM |
21797280 |
LAMA-84 |
Cytotoxic Assay |
|
48 h |
|
IC50=0.74 μM |
21797280 |
A2780/ADR |
Cytotoxic Assay |
|
|
|
IC50=0.194 μM |
21774499 |
A2780 |
Cytotoxic Assay |
|
|
|
IC50=0.0012 μM |
21774499 |
NCI-H187 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.03 μM |
21741833 |
KATO |
Cytotoxic Assay |
|
72 h |
|
IC50=0.33 μM |
21741833 |
ChaGo |
Cytotoxic Assay |
|
72 h |
|
IC50=0.83 μM |
21741833 |
BT474 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.07 μM |
21741833 |
HFF |
Cytotoxic Assay |
|
72 h |
|
CC50=0.03 μM |
21741131 |
Gurav |
Cytotoxic Assay |
100 μM |
48 h |
DMSO |
GI50<0.1 μM |
21737288 |
ZR-75B |
Cytotoxic Assay |
|
72 h |
|
IC50=2.02 μM |
21721528 |
ZR-75B |
Cytotoxic Assay |
|
72 h |
|
IC50=0.04 μM |
21721528 |
SW620 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.01 μM |
21721528 |
NIH3T3 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.05 μM |
21721528 |
NCI/ADR-RES |
Cytotoxic Assay |
|
72 h |
|
IC50=9.3 μM |
21721528 |
LLC-PK1 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.2 μM |
21721528 |
KBV1 |
Cytotoxic Assay |
|
72 h |
|
IC50=4.7 μM |
21721528 |
KB3-1 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.02 μM |
21721528 |
HEK293 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.42 μM |
21721528 |
HEK293 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.01 μM |
21721528 |
Ew36 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.01 μM |
21721528 |
MG63 |
Growth Inhibition Assay |
|
72 h |
|
IC50=2.8 μM |
21721519 |
PC3 |
Cytotoxic Assay |
160 μg/mL |
5 d |
DMSO |
GI50=0.021 μM |
21711054 |
NCI-H23 |
Cytotoxic Assay |
160 μg/mL |
5 d |
DMSO |
GI50=0.005 μM |
21711054 |
Hs578 |
Cytotoxic Assay |
160 μg/mL |
5 d |
DMSO |
GI50=0.006 μM |
21711054 |
BT549 |
Cytotoxic Assay |
160 μg/mL |
5 d |
DMSO |
GI50=0.01 μM |
21711054 |
HOP62 |
Cytotoxic Assay |
|
24 h |
|
GI50=0.14 μM |
21676506 |
SW480 |
Growth Inhibition Assay |
|
48 h |
|
IC50=0.06 μM |
21641694 |
S180 |
Growth Inhibition Assay |
|
48 h |
|
IC50=29.2 μM |
21620529 |
H22 |
Growth Inhibition Assay |
|
48 h |
|
IC50=36.51 μM |
21620529 |
P388D1 |
Growth Inhibition Assay |
|
|
|
IC50=0.338 μM |
21570750 |
KATOIII |
Growth Inhibition Assay |
|
|
|
IC50=4.38 μM |
21570750 |
SK-MEL-28 |
Growth Inhibition Assay |
25 nM |
24 h |
DMSO |
IC50=0.6 μM |
21553829 |
SF295 |
Growth Inhibition Assay |
25 nM |
24 h |
DMSO |
IC50=4.4 μM |
21553829 |
A375 |
Growth Inhibition Assay |
|
72 h |
PBS |
IC50=0.13 μM |
21496972 |
HCT8 |
Cytotoxic Assay |
0.58 μg/mL |
69 h |
DMSO |
IC50=0.02 μM |
21381705 |
NCI-N87 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.4198 μM |
21296467 |
HUVEC |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.0303 μM |
21296467 |
HepG2 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.019 μM |
21296467 |
CCRF |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.0375 μM |
21296467 |
IMR90 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.59 μM |
21215623 |
Molt4/C8 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.2 μM |
21144624 |
CEM |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.06 μM |
21144624 |
MDA435 |
Cytotoxic Assay |
10 μM |
72 h |
DMSO |
IC50=0.0035 μM |
21142180 |
MDA231 |
Cytotoxic Assay |
10 μM |
72 h |
DMSO |
IC50=4.7x10-5 μM |
21142180 |
HL60R |
Cytotoxic Assay |
10 μM |
72 h |
DMSO |
IC50=0.99 μM |
21142180 |
C33A |
Cytotoxic Assay |
100 μg/mL |
48 h |
|
IC50=0.82 μM |
21071221 |
MKN45 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.00019 μM |
21067930 |
KB |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.00023 μM |
21067930 |
H460 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.00038 μM |
21067930 |
KB8.5 |
Cytotoxic Assay |
50 μM |
72 h |
DMSO |
IC50=3.3 μM |
21035234 |
BJ |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=2.33 μM |
20931970 |
ARPE19 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.76 μM |
20931970 |
THP1 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.008 μM |
20833057 |
SiHa |
Cytotoxic Assay |
4 μM |
24 h |
|
GI50=0.17 μM |
20732817 |
DWD |
Cytotoxic Assay |
4 μM |
24 h |
|
GI50=0.1 μM |
20732817 |
SKOV3 |
Cytotoxic Assay |
|
|
|
IC50=0.001 μM |
20719504 |
Hep3B |
Cytotoxic Assay |
|
11 d |
|
IC50=0.14 μM |
20718475 |
COLO205 |
Cytotoxic Assay |
|
48 h |
DMSO |
GI50=0.1 μM |
20673627 |
HCT-15 |
Cytotoxic Assay |
|
|
|
IC50=0.038 μM |
20594848 |
NUGC3 |
Cytotoxic Assay |
|
|
|
GI50=0.202 μM |
20579876 |
CCRF-CEM |
Growth Inhibition Assay |
|
48 h |
|
GI50=0.02 μM |
20570145 |
HAEC |
Cytotoxic Assay |
100 μM |
24 h |
DMSO |
IC50=13 μM |
20547797 |
PAXF1657L |
Cytotoxic Assay |
10 μM |
24 h |
|
IC50=0.052 μM |
20545334 |
MEXF462NL |
Cytotoxic Assay |
10 μM |
24 h |
|
IC50=0.052 μM |
20545334 |
MAXF401NL |
Cytotoxic Assay |
10 μM |
24 h |
|
IC50=0.052 μM |
20545334 |
GXF251L |
Cytotoxic Assay |
10 μM |
24 h |
|
IC50=0.052 μM |
20545334 |
CEM/ADR5000 |
Function Assay |
1 μg/mL |
6 h |
|
Increase in ROS generation |
20527917 |
CEM/ADR5000 |
Apoptosis Assay |
1 μg/mL |
24 h |
|
Induction of apoptosis |
20527917 |
PCO3 |
Cytotoxic Assay |
250 μg/mL |
48 h |
|
GI50=0.17 μM |
20413188 |
OVCAR-3 |
Cytotoxic Assay |
250 μg/mL |
48 h |
|
GI50=0.07 μM |
20413188 |
NCI/ADR |
Cytotoxic Assay |
250 μg/mL |
48 h |
|
GI50=5.99 μM |
20413188 |
3T3 |
Cytotoxic Assay |
10 μM |
48 h |
|
IC50=3.7 μM |
20405844 |
HBI10A |
Cytotoxic Assay |
|
|
|
CC50<0.3 μM |
20363140 |
U937 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.00445 μM |
20356655 |
NB-1 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.00515 μM |
20356655 |
K562 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.00612 μM |
20356655 |
HL60 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.00113 μM |
20356655 |
GOTO |
Cytotoxic Assay |
|
72 h |
|
IC50=0.00473 μM |
20356655 |
SK-N-MC |
Cytotoxic Assay |
|
72 h |
|
IC50=0.12 μM |
20303768 |
U87MG |
Cytotoxic Assay |
|
48 h |
|
IC50=0.018 μM |
20210346 |
SKHEP1 |
Cytotoxic Assay |
|
48 h |
|
IC50=0.01 μM |
20210346 |
MIAPaCa2 |
Cytotoxic Assay |
100 μM |
72 h |
|
IC50=0.01 μM |
20207049 |
SKHep |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=0.09 μM |
20171108 |
MESSA/DX5 |
Function Assay |
50 μM |
2 h |
water |
Induction of DNA damage assessed as increase in comet-tail length |
20151639 |
MESSA |
Function Assay |
25 μM |
2 h |
water |
Cellular uptake |
20151639 |
MESSA |
Function Assay |
50 μM |
2 h |
water |
Induction of DNA damage assessed as increase in comet-tail length |
20151639 |
MCF10A |
Cytotoxic Assay |
40 μM |
48 h |
DMSO |
IC50=0.18 μM |
20064676 |
IMR32 |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=1.7 μM |
19939522 |
MOLT3 |
Cytotoxic Assay |
|
|
|
IC50=0.04 μM |
19824618 |
HuCCa1 |
Cytotoxic Assay |
|
4 d |
|
IC50=0.64 μM |
19824618 |
HCT15 |
Cytotoxic Assay |
|
|
|
IC50=0.037 μM |
19819696 |
MDA-MB-453 |
Cytotoxic Assay |
0.58 μg/mL |
69 h |
DMSO |
IC50=0.12 μM |
19788290 |
HL60/MX2 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=8.046 μM |
19743858 |
2008/P |
Cytotoxic Assay |
|
5 d |
DMSO |
IC50=0.063 μM |
19725578 |
2008/MRP1 |
Cytotoxic Assay |
|
5 d |
DMSO |
IC50=0.577 μM |
19725578 |
Colon 26-L5 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=3.12 μM |
19689125 |
B16-BL6 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=3.07 μM |
19689125 |
KB |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.001 μM |
19655762 |
HCT116 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.006 μM |
19655762 |
U251 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.6 μM |
19632833 |
OS-RC2 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=5.4 μM |
19632833 |
MOLT4 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.002 μM |
19632833 |
L78 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=2.4 μM |
19632833 |
IMR90 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=1 μM |
19632833 |
SK-N-SH |
Apoptosis Assay |
5 μM |
|
|
Induction of apoptosis assessed as caspase 3 activity |
19631549 |
SK-N-SH |
Apoptosis Assay |
5 μM |
|
|
Induction of apoptosis at 0.5 to 5 uM |
19631549 |
SNU1 |
Cytotoxic Assay |
|
|
|
IC50=4 μM |
19585998 |
MDA-MB-231 |
Growth Inhibition Assay |
200 μM |
48 h |
DMSO |
Antitumor activity against human estrogen receptor deficient MDA-MB-231 cells with GI50 of 0.01086 μM |
19428155 |
U251 |
Function Assay |
1 μM |
16 h |
DMSO |
Inhibition of HIF1 activation in human U251 cells stably transfected in pGL2-TK-HRE plasmid with EC50 of 0.12 μM |
19405508 |
SKOV3 |
Growth Inhibition Assay |
|
|
|
GI50=0.021 μM |
19394218 |
MESSA |
Growth Inhibition Assay |
|
|
|
GI50=0.0051 μM |
19394218 |
A549 |
Growth Inhibition Assay |
|
|
|
GI50=0.003 μM |
19394218 |
A431 |
Growth Inhibition Assay |
|
|
|
GI50=0.0012 μM |
19394218 |
PA1 |
Cytotoxic Assay |
10 μM |
72 h |
|
IC50=0.63 μM |
19361894 |
HBL100 |
Cytotoxic Assay |
10 μM |
72 h |
|
IC50=0.24 μM |
19361894 |
ECV304 |
Cytotoxic Assay |
10 μM |
72 h |
|
Cytotoxicity |
19361894 |
WTK1 |
Function Assay |
0.1 μM |
72 h |
|
Cell cycle arrest in human WTK1 cells expressing p53 M237I mutant assessed as accumulation at sub-G0/G1 phase |
19349174 |
WTK1 |
Function Assay |
25 μM |
8 h |
|
Induction of p53 transcriptional activity in human WTK1 cells expressing p53 M237I mutant assessed as p21-Cip1/Waf1 expression |
19349174 |
WTK1 |
Function Assay |
25 μM |
8 h |
|
Induction of p53 phosphorylation at Ser15 in human WTK1 cells expressing p53 M237I mutant |
19349174 |
WTK1 |
Function Assay |
0.1 μM |
8 h |
|
Induction of p53 transcriptional activity in human WTK1 cells expressing p53 M237I mutant assessed as p21-Cip1/Waf1 expression |
19349174 |
WTK1 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in human WTK1 cells expressing p53 M237I mutant assessed as increase in PARP cleavage |
19349174 |
WTK1 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in human WTK1 cells expressing p53 M237I mutant assessed as decrease in pro-caspase 3 level |
19349174 |
WTK1 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in human WTK1 cells expressing p53 M237I mutant assessed as increase in cleaved caspase 3 level |
19349174 |
WTK1 |
Function Assay |
0.1 μM |
8 h |
|
Induction of p53 phosphorylation at Ser15 in human WTK1 cells expressing p53 M237I mutant |
19349174 |
TK6 |
Function Assay |
25 μM |
8 h |
|
Induction of p53 transcriptional activity in human TK6 cells expressing wild type p53 assessed as p21-Cip1/Waf1 expression |
19349174 |
TK6 |
Function Assay |
25 μM |
8 h |
|
Induction of p53 phosphorylation at Ser15 in human TK6 cells expressing wild type p53 |
19349174 |
TK6 |
Function Assay |
0.1 μM |
72 h |
|
Cell cycle arrest in human TK6 cells expressing wild type p53 assessed as accumulation at sub-G0/G1 phase |
19349174 |
TK6 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in human TK6 cells expressing wild type p53 assessed as increase in PARP cleavage |
19349174 |
TK6 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in human TK6 cells expressing wild type p53 assessed as decrease in pro-caspase 3 level |
19349174 |
TK6 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in human TK6 cells expressing wild type p53 assessed as increase in cleaved caspase 3 level |
19349174 |
TK6 |
Function Assay |
0.1 μM |
8 h |
|
Induction of p53 transcriptional activity in human TK6 cells expressing wild type p53 assessed as p21-Cip1/Waf1 expression |
19349174 |
TK6 |
Function Assay |
0.1 μM |
8 h |
|
Induction of p53 phosphorylation at Ser15 in human TK6 cells expressing wild type p53 |
19349174 |
NH32 |
Growth Inhibition Assay |
0.1 μM |
72 h |
|
Cell cycle arrest in p53 deficient human NH32 cells assessed as accumulation at sub-G0/G1 phase |
19349174 |
NH32 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in p53 deficient human NH32 cells assessed as increase in PARP cleavage |
19349174 |
NH32 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in p53 deficient human NH32 cells assessed as decrease in pro-caspase 3 level |
19349174 |
NH32 |
Apoptosis Assay |
0.1 μM |
8 h |
|
Induction of apoptosis in p53 deficient human NH32 cells assessed as increase in cleaved caspase 3 level |
19349174 |
SMMC-7541 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.0037 μM |
19285863 |
T47D |
Apoptosis Assay |
10 μM |
48 h |
DMSO |
Induction of apoptosis assessed as caspase activation with EC50 of 0.57 μM |
19282188 |
SNU398 |
Apoptosis Assay |
10 μM |
48 h |
DMSO |
Induction of apoptosis assessed as caspase activation with EC50 of 0.39 μM |
19282188 |
MEF |
Cytotoxic Assay |
|
72 h |
|
IC50=3.4 μM |
19186946 |
Hs888Lu |
Cytotoxic Assay |
|
72 h |
|
IC50=1.4 μM |
19186946 |
HL60 |
Cytotoxic Assay |
100 μM |
72 h |
DMSO |
IC50=0.018 μM |
19136263 |
A2780/DX3 |
Function Assay |
10 μM |
2 h |
saline |
Reversal of P-gp 170-mediated multidrug resistance assessed as increase in intracellular doxorubicin accumulation |
19093883 |
XF498 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.16 μM |
19053767 |
MT4 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.003 μM |
19053767 |
HT-29 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.002 μM |
19053767 |
HT-29 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.018 μM |
19028425 |
Bel7402 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.021 μM |
19028425 |
DU145 |
Cytotoxic Assay |
25 μg/mL |
72 h |
|
IC50=0.0039 μM |
18829316 |
MRC5 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.1 μM |
18783950 |
Jurkat |
Cytotoxic Assay |
|
72 h |
|
IC50=0.03 μM |
18783950 |
AW8507 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.17 μM |
18657979 |
AW13516 |
Cytotoxic Assay |
100 μM |
48 h |
|
GI50=0.1 μM |
18657979 |
SK-MEL-2 |
Growth Inhibition Assay |
|
72 h |
|
GI50=0.11 μM |
18585035 |
L1210 |
Function Assay |
0.5 μg/mL |
12 h |
water |
Cell cycle arrest in mouse L1210 cells by accumulation at G2/M phase |
18508273 |
LLC |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.01 μM |
18440233 |
Colon 26-L5 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.01 μM |
18440233 |
MCF7/DX |
Cytotoxic Assay |
|
24 h |
water |
Cytotoxicity against human doxorubicin-resistant MCF7/Dx cells with IC50 of 5.3 μM |
18429610 |
Caco2 |
Function Assay |
50 nM |
48 h |
water |
Decrease in cyclin A expression |
18429610 |
SNU638 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.052 μM |
18321715 |
HT1080 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.022 μM |
18321715 |
Hep2 |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=0.42 μM |
18281125 |
A375 |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=0.01 μM |
18281125 |
K/VP.5 |
Growth Inhibition Assay |
|
72 h |
DMSO |
Growth inhibition of human K/VP.5 cells with IC50 of 0.41 μM |
18258442 |
PC3M |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=1.11 μM |
18247573 |
SJSA1 |
Cytotoxic Assay |
1 μM |
6 h |
|
Cytotoxicity against human SJSA1 cells expressing GRP78 with IC50 of 0.0062 μM |
18243696 |
HepG2 |
Cytotoxic Assay |
100 μM |
72 h |
|
IC50=0.07 μM |
18181575 |
U373MG |
Growth Inhibition Assay |
|
24 h |
DMSO |
Growth inhibition of human U373MG cells containing UhiCE expressing plasmid with IC50 of 0.19953 μM |
18173233 |
U373MG |
Growth Inhibition Assay |
|
24 h |
DMSO |
Growth inhibition of human U373MG cells containing UhCE1 expressing plasmid with IC50 of 0.15849 μM |
18173233 |
U373MG |
Growth Inhibition Assay |
|
24 h |
DMSO |
Growth inhibition of human U373MG cells containing U373IRES plasmid with IC50 of 0.15849 μM |
18173233 |
SNU638 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.07 μM |
18063366 |
SF268 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.04 μM |
18052326 |
W301 |
Growth Inhibition Assay |
50 mM |
48 h |
DMSO |
Growth inhibition of Saccharomyces cerevisiae W301 with IC50 of 10 μM |
18040043 |
Daudi |
Cytotoxic Assay |
100 μM |
96 h |
|
Cytotoxicity against human Daudi cells under deem light with IC50 of 0.3 μM |
17993275 |
2780.9S |
Cytotoxic Assay |
100 μM |
96 h |
|
Cytotoxicity against human 2780.9S cells under deem light with IC50 of 15 μM |
17993275 |
MCF7 |
Growth Inhibition Assay |
100 μM |
72 h |
DMSO |
IC50=0.0007 μM |
17949859 |
KB3.1 |
Growth Inhibition Assay |
100 μM |
72 h |
DMSO |
IC50=0.0004 μM |
17949859 |
WI38 |
Growth Inhibition Assay |
100 μM |
72 h |
|
IC50=0.1 μM |
17935309 |
MIAPaCa2 |
Growth Inhibition Assay |
100 μM |
72 h |
|
IC50=0.024 μM |
17935309 |
UACC257 |
Growth Inhibition Assay |
|
48 h |
|
IC50=0.20893 μM |
17696516 |
RXF393 |
Growth Inhibition Assay |
|
48 h |
|
IC50=0.17783 μM |
17696516 |
IGROVI |
Growth Inhibition Assay |
|
48 h |
|
IC50=0.10965 μM |
17696516 |
BxPc3 |
Growth Inhibition Assay |
|
3 h |
|
IC50=0.31623 μM |
17696516 |
PC3 |
Function Assay |
20 nM |
72 h |
|
Induction of senescence in human PC3 cells |
17658777 |
UO31 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.1 μM |
17656091 |
DLD1 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.1 μM |
17656091 |
UACC62 |
Growth Inhibition Assay |
|
48 h |
DMSO |
GI50=0.094 μM |
17614292 |
LNcaP |
Cytotoxic Assay |
|
|
DMSO |
ED50=0.04 μM |
17591444 |
1A9 |
Cytotoxic Assay |
|
|
DMSO |
ED50=0.02 μM |
17591444 |
ZR-751 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.04 μM |
17585747 |
BGC823 |
Cytotoxic Assay |
|
48 h |
|
IC50=0.35 μM |
17583953 |
2780AD |
Growth Inhibition Assay |
10 μM |
|
|
Growth inhibition of multidrug-resistant human 2780AD cells with IC50 of 0.298 μM |
17490878 |
KB-VIN |
Cytotoxic Assay |
|
72 h |
DMSO |
Cytotoxicity against human multidrug-resistant KB-VIN cells with EC50 of 1.7 μM |
17378530 |
MeVo |
Cytotoxic Assay |
|
48 h |
water |
IC50=0.82 μM |
17375902 |
CEM/VM1 |
Cytotoxic Assay |
|
72 h |
DMSO |
Cytotoxicity against teniposide-resistant CEM/VM1 cells with IC50 of 0.55 μM |
17323939 |
CEM/VLB100 |
Cytotoxic Assay |
|
72 h |
DMSO |
Cytotoxicity against CEM/VLB100 cells with IC50 of 3.71 μM |
17323939 |
K562I/S9 |
Growth Inhibition Assay |
|
72 h |
DMSO |
Antiproliferative activity against human multidrug-resistant K562i/S9 cells expressing Pgp with IC50 of 2 μM |
17276690 |
2780AD |
Cytotoxic Assay |
10 μM |
|
|
Cytotoxicity againt multidrug-resistant human 2780AD cells with IC50 of 0.909 μM |
17239597 |
TRAMP-C2H |
Growth Inhibition Assay |
|
72 h |
water |
GI50=0.0158 μM |
17181166 |
TRAMP-C1A |
Growth Inhibition Assay |
|
72 h |
water |
GI50=0.0204 μM |
17181166 |
K562 |
Growth Inhibition Assay |
|
48 h |
DMSO/methanol |
IC50=0.01 μM |
17181164 |
MDA435/LCC6 |
Growth Inhibition Assay |
|
4 d |
DMSO |
IC50=0.3 μM |
17154505 |
MDA-MB-231 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.03 μM |
17141923 |
A2780 |
Growth Inhibition Assay |
1 μM |
4 d |
DMSO |
Inhibition of doxorubicin-resistant A2780 cell growth with IC50 of 0.061 μM |
17125254 |
A2780 |
Growth Inhibition Assay |
1 μM |
4 d |
DMSO |
Inhibition of A2780 cell growth with IC50 of 0.003 μM |
17125254 |
Vero |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=0.50119 μM |
17125253 |
SK-HEP-1 |
Growth Inhibition Assay |
|
24 h |
DMSO |
IC50=0.05012 μM |
17125253 |
SHP77 |
Growth Inhibition Assay |
|
24 h |
DMSO |
IC50=0.12589 μM |
17125253 |
H9c2 |
Growth Inhibition Assay |
|
24 h |
DMSO |
IC50=0.01995 μM |
17125253 |
AGS |
Cytotoxic Assay |
|
|
|
IC50=0.31 μM |
17125240 |
HA22T |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.31 μM |
17107806 |
HL60/ADR |
Cytotoxic Assay |
1 mM |
72 h |
DMSO |
Cytotoxicity against adriamycin-resistant HL60/ADR cells expressing MRP1 with IC50 of 2 μM |
17069934 |
BC |
Cytotoxic Assay |
|
|
|
IC50=0.288 μM |
16933890 |
Wil2-NS |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.02 μM |
16913700 |
G361 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.09 μM |
16913700 |
C8166 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.02 μM |
16913700 |
ACHN |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.001 μM |
16913700 |
5637 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.02 μM |
16913700 |
MCF7 |
Function Assay |
0.5 μg/mL |
24 h |
DMSO |
Inhibition of p53-mediated transactivation |
16862141 |
VA13 |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=0.22 μM |
16499322 |
MESSA/DX5 |
Cytotoxic Assay |
|
|
|
Cytotoxicity against multidrug-resistant MES-SA/Dx5 cells with IC50 of 1.56 μM |
16169719 |
MES-SA |
Cytotoxic Assay |
|
|
|
IC50=0.016 μM |
16169719 |
HSG |
Cytotoxic Assay |
|
24 h |
|
CC50=1.9 μM |
15745812 |
HSC-2 |
Cytotoxic Assay |
|
24 h |
|
CC50=0.68 μM |
15745812 |
NCI-H69 |
Cytotoxic Assay |
|
6 d |
|
IC50=0.0113 μM |
15743178 |
VA13 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.38 μM |
15730243 |
MeVo |
Growth Inhibition Assay |
|
24 h |
water |
IC50=0.82 μM |
15715481 |
WI38 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.3 μM |
15620238 |
Rtx6 |
Growth Inhibition Assay |
|
4 h |
DMSO |
Growth inhibition of ER expressing Rtx6 cells |
15588086 |
MEL-28 |
Cytotoxic Assay |
|
|
|
IC50=0.03 μM |
15225700 |
Col2 |
Cytotoxic Assay |
|
72 h |
DMSO |
IC50=0.52 μM |
15177438 |
U937/GTB |
Cytotoxic Assay |
|
72 h |
|
IC50=0.1 μM |
14987049 |
RPMI8226 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.1 μM |
14987049 |
T47D |
Cytotoxic Assay |
|
72 h |
|
IC50=0.007 μM |
14980672 |
MD-MB468 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.007 μM |
14980672 |
TRAMP-C2G |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.0287 μM |
14971910 |
TRAMP-C2D |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.0465 μM |
14971910 |
MDA-MB-435 |
Growth Inhibition Assay |
|
4 h |
DMSO |
IC50=0.15 μM |
14971899 |
PANC-1 |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=3.5 μM |
14971893 |
MEL-28 |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=3.1 μM |
14971893 |
LOVO |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=0.01 μM |
14971893 |
LNcaP |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=0.02 μM |
14971893 |
IGROV |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=4.4 μM |
14971893 |
HeLa |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=0.01 μM |
14971893 |
DU145 |
Growth Inhibition Assay |
|
72 h |
DMSO |
GI50=0.02 μM |
14971893 |
DuPRO |
Cytotoxic Assay |
|
|
|
EC50=1.8 μM |
14667208 |
SF268 |
Cytotoxic Assay |
|
|
|
GI50=8.5 × 10-7 μg/mL |
14640532 |
MCF7 |
Cytotoxic Assay |
|
|
|
GI50=8.0 × 10-7 μg/mL |
14640532 |
H460 |
Cytotoxic Assay |
|
|
|
GI50=3.0 × 10-7 μg/mL |
14640532 |
HT1080 |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.059 μM |
14640513 |
Neuro2A |
Function Assay |
3 ug/mL |
24 h |
|
Neuritogenic activity assessed as morphological changes |
14575440 |
RXF944L |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.06 μM |
12852768 |
LXF629L |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.07 μM |
12852768 |
LXF529L |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.03 μM |
12852768 |
401NL |
Growth Inhibition Assay |
|
72 h |
DMSO |
IC50=0.01 μM |
12852768 |
L2987 |
Cytotoxic Assay |
|
|
|
IC50=0.3 μM |
12798317 |
P388 |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.015 μM |
12620081 |
Jurkat |
Growth Inhibition Assay |
|
72 h |
|
IC50=0.0096 μM |
12620081 |
8226/S |
Cytotoxic Assay |
|
72 h |
DMSO |
Cytotoxity against 8226/S |
12570378 |
8226/DOX1V |
Cytotoxic Assay |
|
72 h |
DMSO |
Cytotoxity against 8226/DOX1V |
12570378 |
LXFL529 |
Growth Inhibition Assay |
|
36 h |
|
IC50=0.04 μM |
12459020 |
L1210 |
Cytotoxic Assay |
|
48 h |
DMSO |
IC50=0.025 μM |
12443763 |
HET-SR-2SC-LNM |
Growth Inhibition Assay |
|
72 h |
deionized water |
IC50=0.052 μM |
12431060 |
2SC/20 |
Growth Inhibition Assay |
|
72 h |
deionized water |
IC50=0.62 μM |
12431060 |
Wil-NS |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.02 μM |
12431049 |
Raji |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.03 μM |
12431049 |
Hep-2 |
Growth Inhibition Assay |
|
96 h |
DMSO |
IC50=0.04 μM |
12431049 |
SK-MES-1 |
Cytotoxic Assay |
|
6 d |
DMSO |
IC50=0.03 μM |
12431048 |
SKMEL-28 |
Cytotoxic Assay |
|
6 d |
DMSO |
IC50=0.06 μM |
12431048 |
CRL7065 |
Cytotoxic Assay |
|
6 d |
DMSO |
IC50=0.5 μM |
12431048 |
UMUC3 |
Cytotoxic Assay |
|
|
|
IC50=0.0092 μM |
12392727 |
U251 |
Cytotoxic Assay |
|
|
|
IC50=0.09 μM |
12039588 |
H69P |
Growth Inhibition Assay |
|
4 d |
|
IC50=0.027 μM |
11806725 |
H69/LX4 |
Growth Inhibition Assay |
|
4 d |
|
Inhibitory activity against drug resistant H69/LX4 cell overexpressing P-glycoprotein with IC50 of 0.137 μM |
11806725 |
H69P |
Cytotoxic Assay |
|
5-6 d |
|
IC50=0.0273 μM |
11806724 |
COR-L23 |
Cytotoxic Assay |
|
5-6 d |
|
IC50=0.0201 μM |
11806724 |
HCT116 |
Growth Inhibition Assay |
|
|
|
GI50=0.023 μM |
11755363 |
SKVLB1 |
Cytotoxic Assay |
|
72 h |
DMSO |
Cytotoxicity against human multidrug-resistant SKVLB1 cell with IC50 of 2.2 μM |
11754602 |
UACC62 |
Cytotoxic Assay |
|
3-5 m |
DMSO |
GI50=0.094 μM |
11678649 |
U87 |
Cytotoxic Assay |
10 μM |
|
DMSO |
Cytotoxicity against U87 resistant cell with IC50 of 0.14 μM |
11606141 |
U87 |
Cytotoxic Assay |
10 μM |
|
DMSO |
Cytotoxicity against U87 sensitive cell with IC50 of 0.06 μM |
11606141 |
U373 |
Cytotoxic Assay |
10 μM |
|
DMSO |
Cytotoxicity against U373 sensitive cell with IC50 of 0.01 μM |
11606141 |
T24 |
Cytotoxic Assay |
10 μM |
|
DMSO |
Cytotoxicity against T24 sensitive cell with IC50 of 0.02 μM |
11606141 |
LoVo |
Cytotoxic Assay |
10 μM |
|
DMSO |
Cytotoxicity against LoVo sensitive cell with IC50 of 0.008 μM |
11606141 |
J82 |
Cytotoxic Assay |
10 μM |
|
DMSO |
Cytotoxicity against J82 sensitive cell with IC50 of 0.03 μM |
11606141 |
CNS |
Growth Inhibition Assay |
|
48 h |
|
GI50=0.064 μM |
11473418 |
RENCA |
Growth Inhibition Assay |
|
48 h |
|
IC50<0.01 μM |
11454467 |
CH1 |
Cytotoxic Assay |
|
96 h |
DMSO |
IC50=0.0063 μM |
11123989 |
UA375 |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=0.112 μM |
10956214 |
OVCAR-3 |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=0.035 μM |
10956214 |
D40 |
Cytotoxic Assay |
|
24 h |
DMSO |
IC50=1.172 μM |
10956214 |
L1210 |
Cytotoxic Assay |
|
|
|
IC50=0.025 μM |
10890167 |
ZR-75-1 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against ZR-75-1 cell (ER+,pgr+,mutant p53) with IC50 of 0.009 μM |
10780913 |
T47D |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against T47D cell (ER+,mutant p53) with IC50 of 0.007 μM |
10780913 |
SKBR-3 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against SKBR-3 cell (ER-amplified erB2,mutant p53) with IC50 of 0.02 μM |
10780913 |
NCI-H647 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against NCI-H647 cell (mutant p53) with IC50 of 0.001 μM |
10780913 |
NCI-H358 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against NCI-H358 cell (mutant p53) with IC50 of 0.13 μM |
10780913 |
NCI-H322 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against NCI-H322 cell (mutant p53) with IC50 of 0.03 μM |
10780913 |
NCI-H226 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against NCI-H226 cell (mutant p53) with IC50 of 0.008 μM |
10780913 |
MDA-468 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against MDA-468 cell (ER-, amplified EGFR, mutant p53) with IC50 of 0.005 μM |
10780913 |
MDA-231 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
Cytotoxicity against MDA-231 cell (ER-,EGFR+,mutant p53) with IC50 of 0.006 μM |
10780913 |
H460pv8 |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
IC50=0.004 μM |
10780913 |
H460pv8/eto |
Cytotoxic Assay |
100 μM |
48 h |
Saline |
IC50=0.02 μM |
10780913 |
U937 |
Function Assay |
|
24 h |
DMSO |
Inhibits incorporation of [3H]thymidine with IC50 of 0.1 μM |
10780911 |
T24 |
Growth Inhibition Assay |
|
|
|
IC50=0.64 μM |
10698436 |
PC14 |
Growth Inhibition Assay |
|
|
|
IC50=1.9 μM |
10698436 |
MKN-1 |
Growth Inhibition Assay |
|
|
|
IC50=0.64 μM |
10698436 |
HMV-1 |
Growth Inhibition Assay |
|
|
|
IC50=0.28 μM |
10698436 |
P388 |
Cytotoxic Assay |
|
72 h |
|
GI50=0.012 μM |
10691710 |
3Y1 |
Cytotoxic Assay |
|
72 h |
|
GI50=0.0038 μM |
10691710 |
PACA-2 |
Cytotoxic Assay |
|
6 d |
|
ED50=0.0063 μM |
10498214 |
K562R |
Cytotoxic Assay |
|
72 h |
|
IC50=0.0156 μM |
10479282 |
DU145 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.0528 μM |
10479282 |
MEL-AC |
Cytotoxic Assay |
100 μM |
|
|
IC50=1.2 μM |
10476861 |
HTB-54 |
Cytotoxic Assay |
100 μM |
|
|
IC50=1.1 μM |
10476861 |
KB |
Growth Inhibition Assay |
|
4 d |
DMSO |
Antiproliferative activity against drug-resistant KBV20C with IC50 of 0.4 μM |
10411476 |
KB |
Growth Inhibition Assay |
|
4 d |
DMSO |
Antiproliferative activity against drug-resistant KBMDR with IC50 of 0.5 μM |
10411476 |
KB |
Growth Inhibition Assay |
|
4 d |
DMSO |
Antiproliferative activity against drug-resistant KBCampwith IC50 of 0.06 μM |
10411476 |
KB |
Growth Inhibition Assay |
|
4 d |
DMSO |
Antiproliferative activity against drug-resistant KB7D with IC50 of 0.65 μM |
10411476 |
CHO-K1 |
Growth Inhibition Assay |
|
4 d |
DMSO |
IC50=0.4 μM |
10411476 |
CCRF-SB |
Growth Inhibition Assay |
|
4 d |
DMSO |
IC50=0.01 μM |
10411476 |
MDA-MB-361 |
Cytotoxic Assay |
|
1 h |
DMSO |
Cytotoxicity against MDA MB 361 expressing carboxypeptidase stCPG2 with IC50 of 0.018 μM |
10395490 |
MDA-MB-361 |
Cytotoxic Assay |
|
1 h |
DMSO |
Cytotoxicity against MDA-MB-361 expressing LacZ with IC50 of 0.012 μM |
10395490 |
SF-295 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.035 μM |
9873661 |
HOP62 |
Cytotoxic Assay |
|
72 h |
|
IC50=0.004 μM |
9873661 |
PC14 |
Cytotoxic Assay |
|
4 d |
DMSO |
IC50=0.29 μM |
9822542 |
Panc02 |
Growth Inhibition Assay |
10 μM |
6 d |
|
IC50=0.065 μM |
9526570 |
CHO |
Growth Inhibition Assay |
10 μM |
6 d |
|
IC50=0.06 μM |
9526570 |
CA755 |
Growth Inhibition Assay |
10 μM |
6 d |
|
IC50=0.014 μM |
9526570 |
MCF7/VP16 |
Cytotoxic Assay |
50 μg/mL |
72 h |
|
IC50=14.2 μM |
9022792 |
SKVLB |
Cytotoxic Assay |
|
72 h |
|
IC50=6.54 μM |
9003520 |
C6 |
Cytotoxic Assay |
2.5 mg/mL |
5 h |
DMSO |
Cytotoxicity assessed as cell release |
8988604 |
C6 |
Function Assay |
2.5 mg/mL |
4 h |
DMSO |
Inhibition of tubulin polymerization |
8988604 |
C6 |
Cytotoxic Assay |
2.5 mg/mL |
72 h |
DMSO |
Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL |
8988604 |
MCF |
Function Assay |
|
|
|
Reversal of P-gp-mediated multidrug resistance assessed as enhancement in cytotoxicity of adriamycin |
8984151 |
WiDr |
Cytotoxic Assay |
|
|
|
Activity against sensitive WiDr cell with IC50 of 0.053 μM |
8960558 |
MXF7 |
Cytotoxic Assay |
|
|
|
Antitumor activity against doxorubicin-resistant MXF7 with IC50 of 1.172 μM |
8960558 |
MXF7 |
Cytotoxic Assay |
|
|
|
Antitumor activity against MXF7 with IC50 of 0.028 μM |
8960558 |
MXF7 |
Cytotoxic Assay |
|
|
|
Antitumor activity against sensitive MXF7 with IC50 of 0.028 μM |
8960558 |
A2780-DX5 |
Cytotoxic Assay |
|
|
|
Cytotoxicity against doxorubicin-resistant A2780-DX5 with IC50 of 0.357 μM |
8831755 |
A2780-CP3 |
Cytotoxic Assay |
|
|
|
Cytotoxicity against A2780-CP3 with IC50 of 0.056 μM |
8831755 |
A2780-C25 |
Cytotoxic Assay |
|
|
|
Cytotoxicity against A2780-C25 with IC50 of 0.063 μM |
8831755 |
AUC375 |
Growth Inhibition Assay |
|
|
|
IC50=0.112 μM |
8648600 |
SKVLB |
Cytotoxic Assay |
|
|
|
IC50=5.6 μM |
8576914 |
EAC |
Cytotoxic Assay |
|
72 h |
|
IC50=0.35 μM |
8350087 |
C38 |
Cytotoxic Assay |
|
|
|
IC50=0.01 μM |
8057291 |
LOX |
Cytotoxic Assay |
|
|
|
IC50=0.042 μM |
7853331 |
H2981 |
Cytotoxic Assay |
|
|
|
IC50=0.5 μM |
7731023 |
EMT6 |
Growth Inhibition Assay |
0.5 μM |
1 h |
|
Inhibition of proliferation by measuring for surviving fractions with ED50 of 0.0001 μM |
7452674 |
HT-29 |
Growth Inhibition Assay |
0.01 μg |
48 h |
|
Antiproliferative activity |
2778449 |
KBM-3 |
Growth Inhibition Assay |
|
|
|
IC50=0.026 μM |
1995877 |
MLM |
Cytotoxic Assay |
|
|
|
ED50=0.13 μM |
1875350 |
SKMEL-5 |
Growth Inhibition Assay |
|
|
|
ED50=3.2 μM |
1613753 |
T-MT4 |
Growth Inhibition Assay |
|
|
|
ID50=0.01 μM |
1548681 |
T-H9 |
Growth Inhibition Assay |
|
|
|
ID50=0.01 μM |
1548681 |
T-C8166 |
Growth Inhibition Assay |
|
|
|
ID50=0.01 μM |
1548681 |
H9 |
Growth Inhibition Assay |
|
|
|
Inhibition of H9 cells chronically infected with the HIV-1 (H9/IIIB) with ID50 of 0.01 μM |
1548681 |
N417 |
Growth Inhibition Assay |
|
|
|
IC50=0.23 μM |
1479585 |
H69 |
Growth Inhibition Assay |
|
|
|
IC50=0.87 μM |
1479585 |
MCF7/ADR |
Growth Inhibition Assay |
|
|
|
IC50=3.1 μM |
1447730 |
8226/ADR |
Growth Inhibition Assay |
|
|
|
IC50=0.56 μM |
1447730 |
8226 |
Growth Inhibition Assay |
|
|
|
IC50=0.033 μM |
1447730 |
CHO |
Growth Inhibition Assay |
|
|
|
IC50=0.06 μM |
1354750 |
Yoshida sarcoma |
Function Assay |
|
|
|
Inhibition of [3H]TdR incorporation with IC50 of 0.02 μM |
1322986 |
L1210 |
Function Assay |
|
|
|
Inhibition of RNA synthesis with ED50 of 0.58 μM |
490536 |
A431 |
Cytotoxic Assay |
|
|
|
IC50=0.00135 μM |
24890652 |
HT-29 |
Function Assay |
25 μM |
24 h |
|
Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in drug accumulation |
24900337 |
HT-29 |
Function Assay |
5 μM |
24 h |
|
Inhibition of MRP3 in doxorubicin-resistant human HT-29 cells assessed as nitration of tyrosine residues |
24900337 |
HT-29 |
Function Assay |
5 μM |
1 h |
|
Inhibition of MRP3-mediated drug resistance in doxorubicin-resistant human HT-29 cells assessed as increase in drug accumulation |
24900337 |
HT-29 |
Function Assay |
5 μM |
1 h |
|
Induction of nitrite production in doxorubicin-resistant human HT-29 cells |
24900337 |
NAR |
Function Assay |
5 μM |
2 h |
|
Drug uptake in doxorubicin-resistant human NAR cell plasma membrane |
24900344 |
NAR |
Cytotoxic Assay |
10 μM |
24 h |
|
Cytotoxicity assessed as induction of cell death |
24900344 |
NAR |
Cytotoxic Assay |
100 μM |
24 h |
|
Cytotoxicity against doxorubicin-resistant human NAR cells assessed as cell viability |
24900344 |
DA-3 |
Cytotoxic Assay |
60 μM |
24 h |
|
IC50=4 μM |
24900668 |
DA-3 |
Function Assay |
10 μM |
10 h |
|
Cellular uptake in mouse DA-3 cell mitochondria |
24900668 |
DA-3 |
Function Assay |
10 μM |
10 h |
|
Cellular uptake in mouse DA-3 cell lysosome |
24900668 |
DA-3 |
Function Assay |
10 μM |
10 h |
|
Cellular uptake in mouse DA-3 cell nucleus |
24900668 |
YOYO1 |
Function Assay |
|
|
|
Displacement of YOYO1 from phage lambda DNA with IC50 of 0.6 μM |
24900668 |
KCL22 |
Growth Inhibition Assay |
|
48 h |
|
IC50=1.8 μM |
24941129 |
Saos2 |
Growth Inhibition Assay |
40 μM |
24 h |
DMSO |
IC50=0.33 μM |
24941130 |
IMR32 |
Cytotoxic Assay |
250 μM |
48 h |
DMSO |
IC50=0.0051 μM |
24996140 |
NTERA-S-cl-D1 |
Growth Inhibition Assay |
|
|
|
IC50=1.37 nM |
SANGER |
EW-16 |
Growth Inhibition Assay |
|
|
|
IC50=1.91 nM |
SANGER |
HUTU-80 |
Growth Inhibition Assay |
|
|
|
IC50=2.12 nM |
SANGER |
KS-1 |
Growth Inhibition Assay |
|
|
|
IC50=3.44 nM |
SANGER |
HT-144 |
Growth Inhibition Assay |
|
|
|
IC50=3.51 nM |
SANGER |
MFH-ino |
Growth Inhibition Assay |
|
|
|
IC50=3.99 nM |
SANGER |
LC-2 |
Growth Inhibition Assay |
|
|
|
IC50=5.07 nM |
SANGER |
SW982 |
Growth Inhibition Assay |
|
|
|
IC50=6.05 nM |
SANGER |
ES4 |
Growth Inhibition Assay |
|
|
|
IC50=6.11 nM |
SANGER |
KGN |
Growth Inhibition Assay |
|
|
|
IC50=6.34 nM |
SANGER |
RH-1 |
Growth Inhibition Assay |
|
|
|
IC50=6.73 nM |
SANGER |
IGROV-1 |
Growth Inhibition Assay |
|
|
|
IC50=7.2 nM |
SANGER |
KYSE-270 |
Growth Inhibition Assay |
|
|
|
IC50=7.21 nM |
SANGER |
TE-8 |
Growth Inhibition Assay |
|
|
|
IC50=7.5 nM |
SANGER |
Daoy |
Growth Inhibition Assay |
|
|
|
IC50=8.07 nM |
SANGER |
REH |
Growth Inhibition Assay |
|
|
|
IC50=8.11 nM |
SANGER |
786-0 |
Growth Inhibition Assay |
|
|
|
IC50=8.47 nM |
SANGER |
A375 |
Growth Inhibition Assay |
|
|
|
IC50=9.17 nM |
SANGER |
EW-13 |
Growth Inhibition Assay |
|
|
|
IC50=9.63 nM |
SANGER |
MKN1 |
Growth Inhibition Assay |
|
|
|
IC50=9.86 nM |
SANGER |
MV-4-11 |
Growth Inhibition Assay |
|
|
|
IC50=10.03 nM |
SANGER |
ESS-1 |
Growth Inhibition Assay |
|
|
|
IC50=11.09 nM |
SANGER |
PSN1 |
Growth Inhibition Assay |
|
|
|
IC50=11.22 nM |
SANGER |
MCF7 |
Growth Inhibition Assay |
|
|
|
IC50=11.65 nM |
SANGER |
A427 |
Growth Inhibition Assay |
|
|
|
IC50=11.81 nM |
SANGER |
NCI-H1651 |
Growth Inhibition Assay |
|
|
|
IC50=11.83 nM |
SANGER |
LCLC-97TM1 |
Growth Inhibition Assay |
|
|
|
IC50=11.83 nM |
SANGER |
DU-4475 |
Growth Inhibition Assay |
|
|
|
IC50=12.1 nM |
SANGER |
SK-LU-1 |
Growth Inhibition Assay |
|
|
|
IC50=12.54 nM |
SANGER |
NCI-H460 |
Growth Inhibition Assay |
|
|
|
IC50=12.7 nM |
SANGER |
A204 |
Growth Inhibition Assay |
|
|
|
IC50=12.88 nM |
SANGER |
AGS |
Growth Inhibition Assay |
|
|
|
IC50=13.27 nM |
SANGER |
NCI-H2228 |
Growth Inhibition Assay |
|
|
|
IC50=13.48 nM |
SANGER |
HGC-27 |
Growth Inhibition Assay |
|
|
|
IC50=13.56 nM |
SANGER |
RPMI-2650 |
Growth Inhibition Assay |
|
|
|
IC50=13.69 nM |
SANGER |
ES1 |
Growth Inhibition Assay |
|
|
|
IC50=13.72 nM |
SANGER |
MEL-JUSO |
Growth Inhibition Assay |
|
|
|
IC50=14.5 nM |
SANGER |
HT-1080 |
Growth Inhibition Assay |
|
|
|
IC50=14.82 nM |
SANGER |
OCUB-M |
Growth Inhibition Assay |
|
|
|
IC50=15.15 nM |
SANGER |
23132-87 |
Growth Inhibition Assay |
|
|
|
IC50=15.42 nM |
SANGER |
KYSE-510 |
Growth Inhibition Assay |
|
|
|
IC50=15.48 nM |
SANGER |
ST486 |
Growth Inhibition Assay |
|
|
|
IC50=15.53 nM |
SANGER |
639-V |
Growth Inhibition Assay |
|
|
|
IC50=15.91 nM |
SANGER |
COLO-679 |
Growth Inhibition Assay |
|
|
|
IC50=15.97 nM |
SANGER |
CTV-1 |
Growth Inhibition Assay |
|
|
|
IC50=16.07 nM |
SANGER |
BFTC-905 |
Growth Inhibition Assay |
|
|
|
IC50=16.18 nM |
SANGER |
SW954 |
Growth Inhibition Assay |
|
|
|
IC50=16.93 nM |
SANGER |
CAL-51 |
Growth Inhibition Assay |
|
|
|
IC50=17.32 nM |
SANGER |
SW1710 |
Growth Inhibition Assay |
|
|
|
IC50=17.4 nM |
SANGER |
HCC2998 |
Growth Inhibition Assay |
|
|
|
IC50=17.44 nM |
SANGER |
A2058 |
Growth Inhibition Assay |
|
|
|
IC50=17.65 nM |
SANGER |
HCE-4 |
Growth Inhibition Assay |
|
|
|
IC50=18.07 nM |
SANGER |
MEL-HO |
Growth Inhibition Assay |
|
|
|
IC50=18.3 nM |
SANGER |
SNG-M |
Growth Inhibition Assay |
|
|
|
IC50=18.32 nM |
SANGER |
LS-123 |
Growth Inhibition Assay |
|
|
|
IC50=18.46 nM |
SANGER |
NALM-6 |
Growth Inhibition Assay |
|
|
|
IC50=18.63 nM |
SANGER |
NCI-H810 |
Growth Inhibition Assay |
|
|
|
IC50=18.76 nM |
SANGER |
YKG-1 |
Growth Inhibition Assay |
|
|
|
IC50=18.77 nM |
SANGER |
647-V |
Growth Inhibition Assay |
|
|
|
IC50=18.81 nM |
SANGER |
ONS-76 |
Growth Inhibition Assay |
|
|
|
IC50=18.91 nM |
SANGER |
697 |
Growth Inhibition Assay |
|
|
|
IC50=19.09 nM |
SANGER |
RS4-11 |
Growth Inhibition Assay |
|
|
|
IC50=19.14 nM |
SANGER |
8505C |
Growth Inhibition Assay |
|
|
|
IC50=19.56 nM |
SANGER |
SK-UT-1 |
Growth Inhibition Assay |
|
|
|
IC50=19.96 nM |
SANGER |
DOHH-2 |
Growth Inhibition Assay |
|
|
|
IC50=19.99 nM |
SANGER |
NCCIT |
Growth Inhibition Assay |
|
|
|
IC50=20.13 nM |
SANGER |
LCLC-103H |
Growth Inhibition Assay |
|
|
|
IC50=20.54 nM |
SANGER |
CAL-12T |
Growth Inhibition Assay |
|
|
|
IC50=20.65 nM |
SANGER |
QIMR-WIL |
Growth Inhibition Assay |
|
|
|
IC50=20.72 nM |
SANGER |
SBC-5 |
Growth Inhibition Assay |
|
|
|
IC50=20.74 nM |
SANGER |
769-P |
Growth Inhibition Assay |
|
|
|
IC50=20.76 nM |
SANGER |
A431 |
Growth Inhibition Assay |
|
|
|
IC50=20.87 nM |
SANGER |
KE-37 |
Growth Inhibition Assay |
|
|
|
IC50=21.05 nM |
SANGER |
ES8 |
Growth Inhibition Assay |
|
|
|
IC50=21.07 nM |
SANGER |
22RV1 |
Growth Inhibition Assay |
|
|
|
IC50=21.24 nM |
SANGER |
LOUCY |
Growth Inhibition Assay |
|
|
|
IC50=21.32 nM |
SANGER |
J82 |
Growth Inhibition Assay |
|
|
|
IC50=21.34 nM |
SANGER |
MHH-ES-1 |
Growth Inhibition Assay |
|
|
|
IC50=21.58 nM |
SANGER |
MG-63 |
Growth Inhibition Assay |
|
|
|
IC50=22.08 nM |
SANGER |
8-MG-BA |
Growth Inhibition Assay |
|
|
|
IC50=22.12 nM |
SANGER |
BPH-1 |
Growth Inhibition Assay |
|
|
|
IC50=22.12 nM |
SANGER |
RKO |
Growth Inhibition Assay |
|
|
|
IC50=22.28 nM |
SANGER |
HMV-II |
Growth Inhibition Assay |
|
|
|
IC50=22.6 nM |
SANGER |
NCI-H727 |
Growth Inhibition Assay |
|
|
|
IC50=22.79 nM |
SANGER |
MOLT-4 |
Growth Inhibition Assay |
|
|
|
IC50=22.86 nM |
SANGER |
NCI-H2342 |
Growth Inhibition Assay |
|
|
|
IC50=22.91 nM |
SANGER |
MZ1-PC |
Growth Inhibition Assay |
|
|
|
IC50=23.81 nM |
SANGER |
TE-15 |
Growth Inhibition Assay |
|
|
|
IC50=24.14 nM |
SANGER |
SR |
Growth Inhibition Assay |
|
|
|
IC50=24.41 nM |
SANGER |
CCRF-CEM |
Growth Inhibition Assay |
|
|
|
IC50=24.52 nM |
SANGER |
SIG-M5 |
Growth Inhibition Assay |
|
|
|
IC50=25.69 nM |
SANGER |
SK-PN-DW |
Growth Inhibition Assay |
|
|
|
IC50=25.72 nM |
SANGER |
SK-HEP-1 |
Growth Inhibition Assay |
|
|
|
IC50=25.86 nM |
SANGER |
SW620 |
Growth Inhibition Assay |
|
|
|
IC50=26.63 nM |
SANGER |
HSC-2 |
Growth Inhibition Assay |
|
|
|
IC50=26.78 nM |
SANGER |
CAL-148 |
Growth Inhibition Assay |
|
|
|
IC50=26.9 nM |
SANGER |
COLO-205 |
Growth Inhibition Assay |
|
|
|
IC50=26.99 nM |
SANGER |
EoL-1-cell |
Growth Inhibition Assay |
|
|
|
IC50=27.78 nM |
SANGER |
KYSE-150 |
Growth Inhibition Assay |
|
|
|
IC50=27.78 nM |
SANGER |
G-361 |
Growth Inhibition Assay |
|
|
|
IC50=28.88 nM |
SANGER |
PANC-03-27 |
Growth Inhibition Assay |
|
|
|
IC50=28.16 nM |
SANGER |
NCI-H2030 |
Growth Inhibition Assay |
|
|
|
IC50=28.26 nM |
SANGER |
NCI-H441 |
Growth Inhibition Assay |
|
|
|
IC50=28.42 nM |
SANGER |
A388 |
Growth Inhibition Assay |
|
|
|
IC50=28.46 nM |
SANGER |
BHY |
Growth Inhibition Assay |
|
|
|
IC50=28.88 nM |
SANGER |
KALS-1 |
Growth Inhibition Assay |
|
|
|
IC50=29.33 nM |
SANGER |
NKM-1 |
Growth Inhibition Assay |
|
|
|
IC50=29.47 nM |
SANGER |
BB30-HNC |
Growth Inhibition Assay |
|
|
|
IC50=29.85 nM |
SANGER |
G-401 |
Growth Inhibition Assay |
|
|
|
IC50=30.2 nM |
SANGER |
EW-7 |
Growth Inhibition Assay |
|
|
|
IC50=30.63 nM |
SANGER |
CAN |
Growth Inhibition Assay |
|
|
|
IC50=31.12 nM |
SANGER |
M059J |
Growth Inhibition Assay |
|
|
|
IC50=31.37 nM |
SANGER |
SK-MES-1 |
Growth Inhibition Assay |
|
|
|
IC50=31.5 nM |
SANGER |
5637 |
Growth Inhibition Assay |
|
|
|
IC50=31.87 nM |
SANGER |
MKN28 |
Growth Inhibition Assay |
|
|
|
IC50=31.91 nM |
SANGER |
COR-L23 |
Growth Inhibition Assay |
|
|
|
IC50=31.96 nM |
SANGER |
CAL-27 |
Growth Inhibition Assay |
|
|
|
IC50=32.57 nM |
SANGER |
CAL-62 |
Growth Inhibition Assay |
|
|
|
IC50=32.79 nM |
SANGER |
C-33-A |
Growth Inhibition Assay |
|
|
|
IC50=32.89 nM |
SANGER |
RT-112 |
Growth Inhibition Assay |
|
|
|
IC50=32.92 nM |
SANGER |
KU812 |
Growth Inhibition Assay |
|
|
|
IC50=33.24 nM |
SANGER |
C8166 |
Growth Inhibition Assay |
|
|
|
IC50=33.31 nM |
SANGER |
VA-ES-BJ |
Growth Inhibition Assay |
|
|
|
IC50=33.36 nM |
SANGER |
NEC8 |
Growth Inhibition Assay |
|
|
|
IC50=33.61 nM |
SANGER |
EB2 |
Growth Inhibition Assay |
|
|
|
IC50=33.73 nM |
SANGER |
COLO-680N |
Growth Inhibition Assay |
|
|
|
IC50=33.87 nM |
SANGER |
IGR-1 |
Growth Inhibition Assay |
|
|
|
IC50=33.83 nM |
SANGER |
MZ2-MEL |
Growth Inhibition Assay |
|
|
|
IC50=33.92 nM |
SANGER |
MIA-PaCa-2 |
Growth Inhibition Assay |
|
|
|
IC50=34.24 nM |
SANGER |
IMR-5 |
Growth Inhibition Assay |
|
|
|
IC50=34.68 nM |
SANGER |
CHP-212 |
Growth Inhibition Assay |
|
|
|
IC50=34.96 nM |
SANGER |
CCF-STTG1 |
Growth Inhibition Assay |
|
|
|
IC50=35.5 nM |
SANGER |
SK-MEL-30 |
Growth Inhibition Assay |
|
|
|
IC50=35.61 nM |
SANGER |
HLE |
Growth Inhibition Assay |
|
|
|
IC50=35.8 nM |
SANGER |
HOP-62 |
Growth Inhibition Assay |
|
|
|
IC50=35.88 nM |
SANGER |
LB1047-RCC |
Growth Inhibition Assay |
|
|
|
IC50=35.97 nM |
SANGER |
DoTc2-4510 |
Growth Inhibition Assay |
|
|
|
IC50=36.25 nM |
SANGER |
HT-29 |
Growth Inhibition Assay |
|
|
|
IC50=36.57 nM |
SANGER |
HC-1 |
Growth Inhibition Assay |
|
|
|
IC50=37.32 nM |
SANGER |
TE-5 |
Growth Inhibition Assay |
|
|
|
IC50=37.48 nM |
SANGER |
NCI-H1299 |
Growth Inhibition Assay |
|
|
|
IC50=37.59 nM |
SANGER |
CHL-1 |
Growth Inhibition Assay |
|
|
|
IC50=37.73 nM |
SANGER |
NCI-H2122 |
Growth Inhibition Assay |
|
|
|
IC50=37.9 nM |
SANGER |
DEL |
Growth Inhibition Assay |
|
|
|
IC50=38.44 nM |
SANGER |
ES5 |
Growth Inhibition Assay |
|
|
|
IC50=39.22 nM |
SANGER |
CESS |
Growth Inhibition Assay |
|
|
|
IC50=39.36 nM |
SANGER |
NCI-H719 |
Growth Inhibition Assay |
|
|
|
IC50=39.65 nM |
SANGER |
A3-KAW |
Growth Inhibition Assay |
|
|
|
IC50=40.14 nM |
SANGER |
KP-4 |
Growth Inhibition Assay |
|
|
|
IC50=40.77 nM |
SANGER |
NCI-H358 |
Growth Inhibition Assay |
|
|
|
IC50=41.08 nM |
SANGER |
HCC38 |
Growth Inhibition Assay |
|
|
|
IC50=42.5 nM |
SANGER |
MRK-nu-1 |
Growth Inhibition Assay |
|
|
|
IC50=43.66 nM |
SANGER |
NCI-H292 |
Growth Inhibition Assay |
|
|
|
IC50=43.76 nM |
SANGER |
PA-1 |
Growth Inhibition Assay |
|
|
|
IC50=44.48 nM |
SANGER |
CAL-85-1 |
Growth Inhibition Assay |
|
|
|
IC50=44.52 nM |
SANGER |
KYSE-450 |
Growth Inhibition Assay |
|
|
|
IC50=44.71 nM |
SANGER |
IST-MEL1 |
Growth Inhibition Assay |
|
|
|
IC50=44.84 nM |
SANGER |
Ca-Ski |
Growth Inhibition Assay |
|
|
|
IC50=44.84 nM |
SANGER |
OCI-AML2 |
Growth Inhibition Assay |
|
|
|
IC50=45.05 nM |
SANGER |
NUGC-3 |
Growth Inhibition Assay |
|
|
|
IC50=45.2 nM |
SANGER |
HOS |
Growth Inhibition Assay |
|
|
|
IC50=45.29 nM |
SANGER |
NB1 |
Growth Inhibition Assay |
|
|
|
IC50=45.99 nM |
SANGER |
A253 |
Growth Inhibition Assay |
|
|
|
IC50=46.12 nM |
SANGER |
NCI-H209 |
Growth Inhibition Assay |
|
|
|
IC50=48.73 nM |
SANGER |
MC-CAR |
Growth Inhibition Assay |
|
|
|
IC50=48.74 nM |
SANGER |
NCI-H661 |
Growth Inhibition Assay |
|
|
|
IC50=49.03 nM |
SANGER |
SF295 |
Growth Inhibition Assay |
|
|
|
IC50=49.08 nM |
SANGER |
GP5d |
Growth Inhibition Assay |
|
|
|
IC50=49.12 nM |
SANGER |
P12-ICHIKAWA |
Growth Inhibition Assay |
|
|
|
IC50=49.27 nM |
SANGER |
ACHN |
Growth Inhibition Assay |
|
|
|
IC50=49.34 nM |
SANGER |
NCI-H2087 |
Growth Inhibition Assay |
|
|
|
IC50=49.42 nM |
SANGER |
SW48 |
Growth Inhibition Assay |
|
|
|
IC50=49.72 nM |
SANGER |
NCI-H526 |
Growth Inhibition Assay |
|
|
|
IC50=49.96 nM |
SANGER |
Ca9-22 |
Growth Inhibition Assay |
|
|
|
IC50=50.07 nM |
SANGER |
SK-OV-3 |
Growth Inhibition Assay |
|
|
|
IC50=50.12 nM |
SANGER |
KYSE-140 |
Growth Inhibition Assay |
|
|
|
IC50=50.42 nM |
SANGER |
BE-13 |
Growth Inhibition Assay |
|
|
|
IC50=51.02 nM |
SANGER |
ES7 |
Growth Inhibition Assay |
|
|
|
IC50=51.4 nM |
SANGER |
IM-9 |
Growth Inhibition Assay |
|
|
|
IC50=51.43 nM |
SANGER |
A101D |
Growth Inhibition Assay |
|
|
|
IC50=51.48 nM |
SANGER |
CAPAN-1 |
Growth Inhibition Assay |
|
|
|
IC50=51.76 nM |
SANGER |
NCI-H2009 |
Growth Inhibition Assay |
|
|
|
IC50=51.76 nM |
SANGER |
NCI-H522 |
Growth Inhibition Assay |
|
|
|
IC50=51.93 nM |
SANGER |
HuP-T4 |
Growth Inhibition Assay |
|
|
|
IC50=52.22 nM |
SANGER |
BCPAP |
Growth Inhibition Assay |
|
|
|
IC50=52.5 nM |
SANGER |
NCI-H1734 |
Growth Inhibition Assay |
|
|
|
IC50=53 nM |
SANGER |
SK-LMS-1 |
Growth Inhibition Assay |
|
|
|
IC50=53.22 nM |
SANGER |
CGTH-W-1 |
Growth Inhibition Assay |
|
|
|
IC50=53.46 nM |
SANGER |
RPMI-8402 |
Growth Inhibition Assay |
|
|
|
IC50=53.86 nM |
SANGER |
Calu-3 |
Growth Inhibition Assay |
|
|
|
IC50=55.98 nM |
SANGER |
COR-L279 |
Growth Inhibition Assay |
|
|
|
IC50=56.95 nM |
SANGER |
T84 |
Growth Inhibition Assay |
|
|
|
IC50=57.06 nM |
SANGER |
P30-OHK |
Growth Inhibition Assay |
|
|
|
IC50=57.57 nM |
SANGER |
CHP-126 |
Growth Inhibition Assay |
|
|
|
IC50=59.24 nM |
SANGER |
KYSE-180 |
Growth Inhibition Assay |
|
|
|
IC50=59.75 nM |
SANGER |
CAMG |
Growth Inhibition Assay |
|
|
|
IC50=59.96 nM |
SANGER |
EW-1 |
Growth Inhibition Assay |
|
|
|
IC50=61.35 nM |
SANGER |
OVCAR-8 |
Growth Inhibition Assay |
|
|
|
IC50=61.92 nM |
SANGER |
HL-60 |
Growth Inhibition Assay |
|
|
|
IC50=62.56 nM |
SANGER |
8305C |
Growth Inhibition Assay |
|
|
|
IC50=63.12 nM |
SANGER |
IA-LM |
Growth Inhibition Assay |
|
|
|
IC50=63.54 nM |
SANGER |
HCC2157 |
Growth Inhibition Assay |
|
|
|
IC50=63.95 nM |
SANGER |
CTB-1 |
Growth Inhibition Assay |
|
|
|
IC50=64019 nM |
SANGER |
NCI-H1437 |
Growth Inhibition Assay |
|
|
|
IC50=64.64 nM |
SANGER |
U251 |
Growth Inhibition Assay |
|
|
|
IC50=64.89 nM |
SANGER |
ALL-PO |
Growth Inhibition Assay |
|
|
|
IC50=65.03 nM |
SANGER |
NCI-SNU-1 |
Growth Inhibition Assay |
|
|
|
IC50=65.86 nM |
SANGER |
RPMI-6666 |
Growth Inhibition Assay |
|
|
|
IC50=65.99 nM |
SANGER |
DBTRG-05MG |
Growth Inhibition Assay |
|
|
|
IC50=67.11 nM |
SANGER |
PF-382 |
Growth Inhibition Assay |
|
|
|
IC50=67.17 nM |
SANGER |
GT3TKB |
Growth Inhibition Assay |
|
|
|
IC50=67.19 nM |
SANGER |
SCC-3 |
Growth Inhibition Assay |
|
|
|
IC50=67.28 nM |
SANGER |
LU-134-A |
Growth Inhibition Assay |
|
|
|
IC50=67.68 nM |
SANGER |
CAL-33 |
Growth Inhibition Assay |
|
|
|
IC50=67.87 nM |
SANGER |
MC-IXC |
Growth Inhibition Assay |
|
|
|
IC50=67.9 nM |
SANGER |
CPC-N |
Growth Inhibition Assay |
|
|
|
IC50=68.4 nM |
SANGER |
A2780 |
Growth Inhibition Assay |
|
|
|
IC50=68.79 nM |
SANGER |
Daudi |
Growth Inhibition Assay |
|
|
|
IC50=68.96 nM |
SANGER |
GI-1 |
Growth Inhibition Assay |
|
|
|
IC50=69.65 nM |
SANGER |
SW962 |
Growth Inhibition Assay |
|
|
|
IC50=69.95 nM |
SANGER |
MFE-296 |
Growth Inhibition Assay |
|
|
|
IC50=70.49 nM |
SANGER |
H4 |
Growth Inhibition Assay |
|
|
|
IC50=71.56 nM |
SANGER |
AN3-CA |
Growth Inhibition Assay |
|
|
|
IC50=72.32 nM |
SANGER |
HCC1599 |
Growth Inhibition Assay |
|
|
|
IC50=72.54 nM |
SANGER |
HuCCT1 |
Growth Inhibition Assay |
|
|
|
IC50=72.93 nM |
SANGER |
Calu-1 |
Growth Inhibition Assay |
|
|
|
IC50=73.6 nM |
SANGER |
DU-145 |
Growth Inhibition Assay |
|
|
|
IC50=73.73 nM |
SANGER |
IST-SL2 |
Growth Inhibition Assay |
|
|
|
IC50=73.81 nM |
SANGER |
HSC-3 |
Growth Inhibition Assay |
|
|
|
IC50=74.53 nM |
SANGER |
HCC1806 |
Growth Inhibition Assay |
|
|
|
IC50=74.96 nM |
SANGER |
VM-CUB-1 |
Growth Inhibition Assay |
|
|
|
IC50=75.36 nM |
SANGER |
HSC-4 |
Growth Inhibition Assay |
|
|
|
IC50=75.76 nM |
SANGER |
NH-12 |
Growth Inhibition Assay |
|
|
|
IC50=76 nM |
SANGER |
MDA-MB-468 |
Growth Inhibition Assay |
|
|
|
IC50=76.18 nM |
SANGER |
TUR |
Growth Inhibition Assay |
|
|
|
IC50=76.32 nM |
SANGER |
TE-1 |
Growth Inhibition Assay |
|
|
|
IC50=76.35 nM |
SANGER |
CMK |
Growth Inhibition Assay |
|
|
|
IC50=77.42 nM |
SANGER |
LB996-RCC |
Growth Inhibition Assay |
|
|
|
IC50=78.45 nM |
SANGER |
NCI-H1650 |
Growth Inhibition Assay |
|
|
|
IC50=78.62 nM |
SANGER |
DMS-273 |
Growth Inhibition Assay |
|
|
|
IC50=78.9 nM |
SANGER |
NOS-1 |
Growth Inhibition Assay |
|
|
|
IC50=79.14 nM |
SANGER |
NB69 |
Growth Inhibition Assay |
|
|
|
IC50=79.2 nM |
SANGER |
SUP-T1 |
Growth Inhibition Assay |
|
|
|
IC50=79.72 nM |
SANGER |
A172 |
Growth Inhibition Assay |
|
|
|
IC50=80.55 nM |
SANGER |
TE-12 |
Growth Inhibition Assay |
|
|
|
IC50=81.06 nM |
SANGER |
MKN45 |
Growth Inhibition Assay |
|
|
|
IC50=81.51 nM |
SANGER |
LoVo |
Growth Inhibition Assay |
|
|
|
IC50=81.82 nM |
SANGER |
SW1573 |
Growth Inhibition Assay |
|
|
|
IC50=82.81 nM |
SANGER |
ETK-1 |
Growth Inhibition Assay |
|
|
|
IC50=83.01 nM |
SANGER |
ABC-1 |
Growth Inhibition Assay |
|
|
|
IC50=83.45 nM |
SANGER |
COLO-668 |
Growth Inhibition Assay |
|
|
|
IC50=84.47 nM |
SANGER |
UM-UC-3 |
Growth Inhibition Assay |
|
|
|
IC50=86.02 nM |
SANGER |
BC-1 |
Growth Inhibition Assay |
|
|
|
IC50=86.76 nM |
SANGER |
PANC-10-05 |
Growth Inhibition Assay |
|
|
|
IC50=88.45 nM |
SANGER |
ES3 |
Growth Inhibition Assay |
|
|
|
IC50=89.48 nM |
SANGER |
TE-441-T |
Growth Inhibition Assay |
|
|
|
IC50=89.82 nM |
SANGER |
KM-H2 |
Growth Inhibition Assay |
|
|
|
IC50=90.68 nM |
SANGER |
SH-4 |
Growth Inhibition Assay |
|
|
|
IC50=92.11 nM |
SANGER |
SF268 |
Growth Inhibition Assay |
|
|
|
IC50=92.42 nM |
SANGER |
VMRC-RCZ |
Growth Inhibition Assay |
|
|
|
IC50=93.26 nM |
SANGER |
GI-ME-N |
Growth Inhibition Assay |
|
|
|
IC50=93.33 nM |
SANGER |
JEG-3 |
Growth Inhibition Assay |
|
|
|
IC50=95.12 nM |
SANGER |
J-RT3-T3-5 |
Growth Inhibition Assay |
|
|
|
IC50=96.31 nM |
SANGER |
K5 |
Growth Inhibition Assay |
|
|
|
IC50=96.9 nM |
SANGER |
EFO-27 |
Growth Inhibition Assay |
|
|
|
IC50=97.44 nM |
SANGER |
SW1783 |
Growth Inhibition Assay |
|
|
|
IC50=97.99 nM |
SANGER |
CAL-39 |
Growth Inhibition Assay |
|
|
|
IC50=98.24 nM |
SANGER |
LS-441N |
Growth Inhibition Assay |
|
|
|
IC50=99.06 nM |
SANGER |
G-402 |
Growth Inhibition Assay |
|
|
|
IC50=99.09 nM |
SANGER |
MES-SA |
Growth Inhibition Assay |
|
|
|
IC50=99.53 nM |
SANGER |
FADU |
Growth Inhibition Assay |
|
|
|
IC50=102.18 nM |
SANGER |
DJM-1 |
Growth Inhibition Assay |
|
|
|
IC50=102.25 nM |
SANGER |
SU-DHL-1 |
Growth Inhibition Assay |
|
|
|
IC50=102.5 nM |
SANGER |
KYSE-410 |
Growth Inhibition Assay |
|
|
|
IC50=103.46 nM |
SANGER |
NCI-H1618 |
Growth Inhibition Assay |
|
|
|
IC50=104.35 nM |
SANGER |
AU565 |
Growth Inhibition Assay |
|
|
|
IC50=104.51 nM |
SANGER |
SF126 |
Growth Inhibition Assay |
|
|
|
IC50=104.58 nM |
SANGER |
MMAC-SF |
Growth Inhibition Assay |
|
|
|
IC50=106.48 nM |
SANGER |
ChaGo-K-1 |
Growth Inhibition Assay |
|
|
|
IC50=107.95 nM |
SANGER |
NCI-H596 |
Growth Inhibition Assay |
|
|
|
IC50=108.01 nM |
SANGER |
LXF-289 |
Growth Inhibition Assay |
|
|
|
IC50=109.24 nM |
SANGER |
HCC1569 |
Growth Inhibition Assay |
|
|
|
IC50=109.34 nM |
SANGER |
NCI-H2170 |
Growth Inhibition Assay |
|
|
|
IC50=109.92 nM |
SANGER |
ARH-77 |
Growth Inhibition Assay |
|
|
|
IC50=109.99 nM |
SANGER |
BOKU |
Growth Inhibition Assay |
|
|
|
IC50=110.87 nM |
SANGER |
SJSA-1 |
Growth Inhibition Assay |
|
|
|
IC50=111.05 nM |
SANGER |
SW626 |
Growth Inhibition Assay |
|
|
|
IC50=111.71 nM |
SANGER |
EHEB |
Growth Inhibition Assay |
|
|
|
IC50=112.59 nM |
SANGER |
TE-10 |
Growth Inhibition Assay |
|
|
|
IC50=112.68 nM |
SANGER |
MZ7-mel |
Growth Inhibition Assay |
|
|
|
IC50=112.84 nM |
SANGER |
SAS |
Growth Inhibition Assay |
|
|
|
IC50=114.45 nM |
SANGER |
TK10 |
Growth Inhibition Assay |
|
|
|
IC50=114.6 nM |
SANGER |
SW13 |
Growth Inhibition Assay |
|
|
|
IC50=115.26 nM |
SANGER |
HCC1937 |
Growth Inhibition Assay |
|
|
|
IC50=115.84 nM |
SANGER |
SK-NEP-1 |
Growth Inhibition Assay |
|
|
|
IC50=116.26 nM |
SANGER |
OVCAR-5 |
Growth Inhibition Assay |
|
|
|
IC50=116.81 nM |
SANGER |
SW837 |
Growth Inhibition Assay |
|
|
|
IC50=117.95 nM |
SANGER |
BFTC-909 |
Growth Inhibition Assay |
|
|
|
IC50=118.48 nM |
SANGER |
SW872 |
Growth Inhibition Assay |
|
|
|
IC50=120.81 nM |
SANGER |
SF539 |
Growth Inhibition Assay |
|
|
|
IC50=121.72 nM |
SANGER |
MLMA |
Growth Inhibition Assay |
|
|
|
IC50=122.08 nM |
SANGER |
BL-41 |
Growth Inhibition Assay |
|
|
|
IC50=122.22 nM |
SANGER |
LB647-SCLC |
Growth Inhibition Assay |
|
|
|
IC50=123.35 nM |
SANGER |
NCI-H1703 |
Growth Inhibition Assay |
|
|
|
IC50=126.42 nM |
SANGER |
KURAMOCHI |
Growth Inhibition Assay |
|
|
|
IC50=126.76 nM |
SANGER |
ATN-1 |
Growth Inhibition Assay |
|
|
|
IC50=127.7 nM |
SANGER |
SK-CO-1 |
Growth Inhibition Assay |
|
|
|
IC50=129.21 nM |
SANGER |
RPMI-7951 |
Growth Inhibition Assay |
|
|
|
IC50=130.14 nM |
SANGER |
NCI-H1648 |
Growth Inhibition Assay |
|
|
|
IC50=131.94 nM |
SANGER |
NCI-H64 |
Growth Inhibition Assay |
|
|
|
IC50=132.65 nM |
SANGER |
HT-3 |
Growth Inhibition Assay |
|
|
|
IC50=133.04 nM |
SANGER |
NCI-H1770 |
Growth Inhibition Assay |
|
|
|
IC50=133.21 nM |
SANGER |
NB13 |
Growth Inhibition Assay |
|
|
|
IC50=134.55 nM |
SANGER |
NCI-H747 |
Growth Inhibition Assay |
|
|
|
IC50=135.02 nM |
SANGER |
ML-2 |
Growth Inhibition Assay |
|
|
|
IC50=135.16 nM |
SANGER |
CA46 |
Growth Inhibition Assay |
|
|
|
IC50=136.88 nM |
SANGER |
ES6 |
Growth Inhibition Assay |
|
|
|
IC50=137.12 nM |
SANGER |
JiyoyeP-2003 |
Growth Inhibition Assay |
|
|
|
IC50=137.8 nM |
SANGER |
NMC-G1 |
Growth Inhibition Assay |
|
|
|
IC50=139.13 nM |
SANGER |
U-698-M |
Growth Inhibition Assay |
|
|
|
IC50=139.5 nM |
SANGER |
LU-99A |
Growth Inhibition Assay |
|
|
|
IC50=146.55 nM |
SANGER |
NCI-H748 |
Growth Inhibition Assay |
|
|
|
IC50=147.31 nM |
SANGER |
SK-MEL-3 |
Growth Inhibition Assay |
|
|
|
IC50=147.61 nM |
SANGER |
SNB75 |
Growth Inhibition Assay |
|
|
|
IC50=148.65 nM |
SANGER |
BB65-RCC |
Growth Inhibition Assay |
|
|
|
IC50=149.31 nM |
SANGER |
NCI-H1355 |
Growth Inhibition Assay |
|
|
|
IC50=152.24 nM |
SANGER |
SCC-25 |
Growth Inhibition Assay |
|
|
|
IC50=153.73 nM |
SANGER |
OAW-42 |
Growth Inhibition Assay |
|
|
|
IC50=153.84 nM |
SANGER |
MONO-MAC-6 |
Growth Inhibition Assay |
|
|
|
IC50=154.36 nM |
SANGER |
WSU-NHL |
Growth Inhibition Assay |
|
|
|
IC50=154.58 nM |
SANGER |
SNU-423 |
Growth Inhibition Assay |
|
|
|
IC50=155.34 nM |
SANGER |
SBC-1 |
Growth Inhibition Assay |
|
|
|
IC50=156.4 nM |
SANGER |
OVCAR-4 |
Growth Inhibition Assay |
|
|
|
IC50=156.78 nM |
SANGER |
NCI-H2347 |
Growth Inhibition Assay |
|
|
|
IC50=158.34 nM |
SANGER |
CAMA-1 |
Growth Inhibition Assay |
|
|
|
IC50=159.33 nM |
SANGER |
GDM-1 |
Growth Inhibition Assay |
|
|
|
IC50=159.7 nM |
SANGER |
KNS-81-FD |
Growth Inhibition Assay |
|
|
|
IC50=160.32 nM |
SANGER |
no-10 |
Growth Inhibition Assay |
|
|
|
IC50=160.38 nM |
SANGER |
NCI-H2052 |
Growth Inhibition Assay |
|
|
|
IC50=160.47 nM |
SANGER |
DB |
Growth Inhibition Assay |
|
|
|
IC50=161.71 nM |
SANGER |
A4-Fuk |
Growth Inhibition Assay |
|
|
|
IC50=162.48 nM |
SANGER |
HCE-T |
Growth Inhibition Assay |
|
|
|
IC50=164.87 nM |
SANGER |
HuP-T3 |
Growth Inhibition Assay |
|
|
|
IC50=165.55 nM |
SANGER |
BC-3 |
Growth Inhibition Assay |
|
|
|
IC50=165.86 nM |
SANGER |
RVH-421 |
Growth Inhibition Assay |
|
|
|
IC50=169.13 nM |
SANGER |
COLO-800 |
Growth Inhibition Assay |
|
|
|
IC50=171.8 nM |
SANGER |
OMC-1 |
Growth Inhibition Assay |
|
|
|
IC50=172.17 nM |
SANGER |
SJRH30 |
Growth Inhibition Assay |
|
|
|
IC50=172.94 nM |
SANGER |
HEL |
Growth Inhibition Assay |
|
|
|
IC50=175.15 nM |
SANGER |
KLE |
Growth Inhibition Assay |
|
|
|
IC50=175.47 nM |
SANGER |
MEG-01 |
Growth Inhibition Assay |
|
|
|
IC50=176.6 nM |
SANGER |
OAW-28 |
Growth Inhibition Assay |
|
|
|
IC50=178.84 nM |
SANGER |
RD |
Growth Inhibition Assay |
|
|
|
IC50=180.1 nM |
SANGER |
HCC2218 |
Growth Inhibition Assay |
|
|
|
IC50=181.66 nM |
SANGER |
OS-RC-2 |
Growth Inhibition Assay |
|
|
|
IC50=182.49 nM |
SANGER |
HEC-1 |
Growth Inhibition Assay |
|
|
|
IC50=182.83 nM |
SANGER |
SCC-4 |
Growth Inhibition Assay |
|
|
|
IC50=183.71 nM |
SANGER |
ME-180 |
Growth Inhibition Assay |
|
|
|
IC50=186.08 nM |
SANGER |
NB10 |
Growth Inhibition Assay |
|
|
|
IC50=188.09 nM |
SANGER |
SCC-15 |
Growth Inhibition Assay |
|
|
|
IC50=188.24 nM |
SANGER |
COR-L105 |
Growth Inhibition Assay |
|
|
|
IC50=188.92 nM |
SANGER |
HT-1376 |
Growth Inhibition Assay |
|
|
|
IC50=189.01 nM |
SANGER |
RPMI-8866 |
Growth Inhibition Assay |
|
|
|
IC50=192.13 nM |
SANGER |
NCI-H2126 |
Growth Inhibition Assay |
|
|
|
IC50=192.2 nM |
SANGER |
KARPAS-422 |
Growth Inhibition Assay |
|
|
|
IC50=193.41 nM |
SANGER |
COLO-741 |
Growth Inhibition Assay |
|
|
|
IC50=194.58 nM |
SANGER |
IPC-298 |
Growth Inhibition Assay |
|
|
|
IC50=196.21 nM |
SANGER |
OE19 |
Growth Inhibition Assay |
|
|
|
IC50=200.18 nM |
SANGER |
NCI-H1694 |
Growth Inhibition Assay |
|
|
|
IC50=200.26 nM |
SANGER |
SW1990 |
Growth Inhibition Assay |
|
|
|
IC50=201.9 nM |
SANGER |
LNCaP-Clone-FGC |
Growth Inhibition Assay |
|
|
|
IC50=204.47 nM |
SANGER |
LB831-BLC |
Growth Inhibition Assay |
|
|
|
IC50=206.25 nM |
SANGER |
HCT-116 |
Growth Inhibition Assay |
|
|
|
IC50=207.39 nM |
SANGER |
BxPC-3 |
Growth Inhibition Assay |
|
|
|
IC50=210.96 nM |
SANGER |
HT-1197 |
Growth Inhibition Assay |
|
|
|
IC50=212.58 nM |
SANGER |
GB-1 |
Growth Inhibition Assay |
|
|
|
IC50=212.73 nM |
SANGER |
RPMI-8226 |
Growth Inhibition Assay |
|
|
|
IC50=213.37 nM |
SANGER |
L-540 |
Growth Inhibition Assay |
|
|
|
IC50=213.49 nM |
SANGER |
NCI-H1882 |
Growth Inhibition Assay |
|
|
|
IC50=215 nM |
SANGER |
A673 |
Growth Inhibition Assay |
|
|
|
IC50=215.79 nM |
SANGER |
NCI-H650 |
Growth Inhibition Assay |
|
|
|
IC50=217.61 nM |
SANGER |
KM12 |
Growth Inhibition Assay |
|
|
|
IC50=218.15 nM |
SANGER |
KP-N-YS |
Growth Inhibition Assay |
|
|
|
IC50=218.4 nM |
SANGER |
COLO-684 |
Growth Inhibition Assay |
|
|
|
IC50=219.79 nM |
SANGER |
MHH-NB-11 |
Growth Inhibition Assay |
|
|
|
IC50=220.22 nM |
SANGER |
HO-1-N-1 |
Growth Inhibition Assay |
|
|
|
IC50=222.83 nM |
SANGER |
NOMO-1 |
Growth Inhibition Assay |
|
|
|
IC50=224.43 nM |
SANGER |
KYSE-70 |
Growth Inhibition Assay |
|
|
|
IC50=224.66 nM |
SANGER |
NCI-H838 |
Growth Inhibition Assay |
|
|
|
IC50=224.73 nM |
SANGER |
NY |
Growth Inhibition Assay |
|
|
|
IC50=228.49 nM |
SANGER |
NCI-H2196 |
Growth Inhibition Assay |
|
|
|
IC50=229.15 nM |
SANGER |
FTC-133 |
Growth Inhibition Assay |
|
|
|
IC50=229.37 nM |
SANGER |
MHH-PREB-1 |
Growth Inhibition Assay |
|
|
|
IC50=229.82 nM |
SANGER |
SK-MEL-2 |
Growth Inhibition Assay |
|
|
|
IC50=230.3 nM |
SANGER |
Detroit562 |
Growth Inhibition Assay |
|
|
|
IC50=230.72 nM |
SANGER |
NCI-H2405 |
Growth Inhibition Assay |
|
|
|
IC50=234.1 nM |
SANGER |
NCI-H2081 |
Growth Inhibition Assay |
|
|
|
IC50=234.27 nM |
SANGER |
LB2241-RCC |
Growth Inhibition Assay |
|
|
|
IC50=235.11 nM |
SANGER |
SNU-387 |
Growth Inhibition Assay |
|
|
|
IC50=236.08 nM |
SANGER |
PC-14 |
Growth Inhibition Assay |
|
|
|
IC50=236.12 nM |
SANGER |
CAS-1 |
Growth Inhibition Assay |
|
|
|
IC50=238.31 nM |
SANGER |
TE-11 |
Growth Inhibition Assay |
|
|
|
IC50=240.88 nM |
SANGER |
LC4-1 |
Growth Inhibition Assay |
|
|
|
IC50=240.89 nM |
SANGER |
HH |
Growth Inhibition Assay |
|
|
|
IC50=241.46 nM |
SANGER |
JVM-2 |
Growth Inhibition Assay |
|
|
|
IC50=242.17 nM |
SANGER |
KNS-42 |
Growth Inhibition Assay |
|
|
|
IC50=242.67 nM |
SANGER |
T-24 |
Growth Inhibition Assay |
|
|
|
IC50=245.48 nM |
SANGER |
D-392MG |
Growth Inhibition Assay |
|
|
|
IC50=248.5 nM |
SANGER |
KOSC-2 |
Growth Inhibition Assay |
|
|
|
IC50=248.71 nM |
SANGER |
D-283MED |
Growth Inhibition Assay |
|
|
|
IC50=250.13 nM |
SANGER |
BV-173 |
Growth Inhibition Assay |
|
|
|
IC50=250.77 nM |
SANGER |
EW-18 |
Growth Inhibition Assay |
|
|
|
IC50=250.9 nM |
SANGER |
MS-1 |
Growth Inhibition Assay |
|
|
|
IC50=252.53 nM |
SANGER |
Calu-6 |
Growth Inhibition Assay |
|
|
|
IC50=253.55 nM |
SANGER |
GR-ST |
Growth Inhibition Assay |
|
|
|
IC50=255.42 nM |
SANGER |
GAK |
Growth Inhibition Assay |
|
|
|
IC50=256.91 nM |
SANGER |
TE-9 |
Growth Inhibition Assay |
|
|
|
IC50=257.47 nM |
SANGER |
HuH-7 |
Growth Inhibition Assay |
|
|
|
IC50=258.44 nM |
SANGER |
KYSE-520 |
Growth Inhibition Assay |
|
|
|
IC50=260.77 nM |
SANGER |
NCI-H520 |
Growth Inhibition Assay |
|
|
|
IC50=266.61 nM |
SANGER |
HD-MY-Z |
Growth Inhibition Assay |
|
|
|
IC50=272.79 nM |
SANGER |
SW756 |
Growth Inhibition Assay |
|
|
|
IC50=274.78 nM |
SANGER |
NB12 |
Growth Inhibition Assay |
|
|
|
IC50=277.12 nM |
SANGER |
EW-3 |
Growth Inhibition Assay |
|
|
|
IC50=279.89 nM |
SANGER |
AM-38 |
Growth Inhibition Assay |
|
|
|
IC50=281.52 nM |
SANGER |
NCI-H23 |
Growth Inhibition Assay |
|
|
|
IC50=283.92 nM |
SANGER |
GOTO |
Growth Inhibition Assay |
|
|
|
IC50=285.56 nM |
SANGER |
NCI-H1693 |
Growth Inhibition Assay |
|
|
|
IC50=290.32 nM |
SANGER |
MOLT-16 |
Growth Inhibition Assay |
|
|
|
IC50=290.5 nM |
SANGER |
HOP-92 |
Growth Inhibition Assay |
|
|
|
IC50=290.7 nM |
SANGER |
MDA-MB-361 |
Growth Inhibition Assay |
|
|
|
IC50=292.65 nM |
SANGER |
Ramos-2G6-4C10 |
Growth Inhibition Assay |
|
|
|
IC50=294.55 nM |
SANGER |
CAL-54 |
Growth Inhibition Assay |
|
|
|
IC50=300.73 nM |
SANGER |
D-263MG |
Growth Inhibition Assay |
|
|
|
IC50=305.52 nM |
SANGER |
SKG-IIIa |
Growth Inhibition Assay |
|
|
|
IC50=311.14 nM |
SANGER |
HAL-01 |
Growth Inhibition Assay |
|
|
|
IC50=313.44 nM |
SANGER |
LAN-6 |
Growth Inhibition Assay |
|
|
|
IC50=315.11 nM |
SANGER |
NCI-H1304 |
Growth Inhibition Assay |
|
|
|
IC50=321.17 nM |
SANGER |
no-11 |
Growth Inhibition Assay |
|
|
|
IC50=321.64 nM |
SANGER |
IST-MES1 |
Growth Inhibition Assay |
|
|
|
IC50=323.35 nM |
SANGER |
L-363 |
Growth Inhibition Assay |
|
|
|
IC50=324.43 nM |
SANGER |
EM-2 |
Growth Inhibition Assay |
|
|
|
IC50=325.41 nM |
SANGER |
DV-90 |
Growth Inhibition Assay |
|
|
|
IC50=329.45 nM |
SANGER |
Saos-2 |
Growth Inhibition Assay |
|
|
|
IC50=329.94 nM |
SANGER |
UMC-11 |
Growth Inhibition Assay |
|
|
|
IC50=331.28 nM |
SANGER |
Raji |
Growth Inhibition Assay |
|
|
|
IC50=334.64 nM |
SANGER |
RXF393 |
Growth Inhibition Assay |
|
|
|
IC50=335.43 nM |
SANGER |
EW-11 |
Growth Inhibition Assay |
|
|
|
IC50=341.56 nM |
SANGER |
BL-70 |
Growth Inhibition Assay |
|
|
|
IC50=342.01 nM |
SANGER |
LB373-MEL-D |
Growth Inhibition Assay |
|
|
|
IC50=344.64 nM |
SANGER |
LU-139 |
Growth Inhibition Assay |
|
|
|
IC50=344.92 nM |
SANGER |
U-87-MG |
Growth Inhibition Assay |
|
|
|
IC50=346.04 nM |
SANGER |
LU-65 |
Growth Inhibition Assay |
|
|
|
IC50=346.4 nM |
SANGER |
U031 |
Growth Inhibition Assay |
|
|
|
IC50=353.87 nM |
SANGER |
HN |
Growth Inhibition Assay |
|
|
|
IC50=354.27 nM |
SANGER |
MHH-CAL-2 |
Growth Inhibition Assay |
|
|
|
IC50=359.21 nM |
SANGER |
NCI-H510A |
Growth Inhibition Assay |
|
|
|
IC50=359.59 nM |
SANGER |
NB5 |
Growth Inhibition Assay |
|
|
|
IC50=359.81 nM |
SANGER |
KG-1 |
Growth Inhibition Assay |
|
|
|
IC50=361.52 nM |
SANGER |
EFO-21 |
Growth Inhibition Assay |
|
|
|
IC50=361.85 nM |
SANGER |
UACC-257 |
Growth Inhibition Assay |
|
|
|
IC50=362.05 nM |
SANGER |
SW1417 |
Growth Inhibition Assay |
|
|
|
IC50=363.23 nM |
SANGER |
NCI-H1417 |
Growth Inhibition Assay |
|
|
|
IC50=370.04 nM |
SANGER |
DSH1 |
Growth Inhibition Assay |
|
|
|
IC50=372.72 nM |
SANGER |
CAKI-1 |
Growth Inhibition Assay |
|
|
|
IC50=375.48 nM |
SANGER |
SIMA |
Growth Inhibition Assay |
|
|
|
IC50=381.86 nM |
SANGER |
LS-1034 |
Growth Inhibition Assay |
|
|
|
IC50=384.51 nM |
SANGER |
K-562 |
Growth Inhibition Assay |
|
|
|
IC50=385.8 nM |
SANGER |
LOXIMVI |
Growth Inhibition Assay |
|
|
|
IC50=389.19 nM |
SANGER |
MC116 |
Growth Inhibition Assay |
|
|
|
IC50=391.41 nM |
SANGER |
MPP-89 |
Growth Inhibition Assay |
|
|
|
IC50=392.94 nM |
SANGER |
SN12C |
Growth Inhibition Assay |
|
|
|
IC50=394.87 nM |
SANGER |
BHT-101 |
Growth Inhibition Assay |
|
|
|
IC50=395.92 nM |
SANGER |
DMS-114 |
Growth Inhibition Assay |
|
|
|
IC50=396.31 nM |
SANGER |
NCI-H1838 |
Growth Inhibition Assay |
|
|
|
IC50=405.05 nM |
SANGER |
HT |
Growth Inhibition Assay |
|
|
|
IC50=405.15 nM |
SANGER |
Caov-3 |
Growth Inhibition Assay |
|
|
|
IC50=406.19 nM |
SANGER |
LB2518-MEL |
Growth Inhibition Assay |
|
|
|
IC50=413.1 nM |
SANGER |
C3A |
Growth Inhibition Assay |
|
|
|
IC50=415.79 nM |
SANGER |
NCI-H226 |
Growth Inhibition Assay |
|
|
|
IC50=416.64 nM |
SANGER |
KMS-12-PE |
Growth Inhibition Assay |
|
|
|
IC50=418.06 nM |
SANGER |
RERF-LC-MS |
Growth Inhibition Assay |
|
|
|
IC50=425.05 nM |
SANGER |
OE33 |
Growth Inhibition Assay |
|
|
|
IC50=426.02 nM |
SANGER |
COLO-678 |
Growth Inhibition Assay |
|
|
|
IC50=427.18 nM |
SANGER |
NCI-H1963 |
Growth Inhibition Assay |
|
|
|
IC50=430.11 nM |
SANGER |
LAMA-84 |
Growth Inhibition Assay |
|
|
|
IC50=437.3 nM |
SANGER |
NCI-H2171 |
Growth Inhibition Assay |
|
|
|
IC50=440.67 nM |
SANGER |
U-266 |
Growth Inhibition Assay |
|
|
|
IC50=451.49 nM |
SANGER |
SNU-C2B |
Growth Inhibition Assay |
|
|
|
IC50=460.97 nM |
SANGER |
T47D |
Growth Inhibition Assay |
|
|
|
IC50=469.69 nM |
SANGER |
TE-6 |
Growth Inhibition Assay |
|
|
|
IC50=469.81 nM |
SANGER |
OVCAR-3 |
Growth Inhibition Assay |
|
|
|
IC50=470.41 nM |
SANGER |
C-4-II |
Growth Inhibition Assay |
|
|
|
IC50=472.56 nM |
SANGER |
EFM-19 |
Growth Inhibition Assay |
|
|
|
IC50=478.27 nM |
SANGER |
NCI-N87 |
Growth Inhibition Assay |
|
|
|
IC50=479.92 nM |
SANGER |
NCI-H187 |
Growth Inhibition Assay |
|
|
|
IC50=493.21 nM |
SANGER |
MDA-MB-157 |
Growth Inhibition Assay |
|
|
|
IC50=499.01 nM |
SANGER |
OPM-2 |
Growth Inhibition Assay |
|
|
|
IC50=501.81 nM |
SANGER |
COLO-320-HSR |
Growth Inhibition Assay |
|
|
|
IC50=513.16 nM |
SANGER |
RMG-I |
Growth Inhibition Assay |
|
|
|
IC50=513.98 nM |
SANGER |
IST-SL1 |
Growth Inhibition Assay |
|
|
|
IC50=517.42 nM |
SANGER |
UACC-893 |
Growth Inhibition Assay |
|
|
|
IC50=521.51 nM |
SANGER |
Becker |
Growth Inhibition Assay |
|
|
|
IC50=521.83 nM |
SANGER |
HPAF-II |
Growth Inhibition Assay |
|
|
|
IC50=527.24 nM |
SANGER |
HCC1954 |
Growth Inhibition Assay |
|
|
|
IC50=540.83 nM |
SANGER |
SNU-449 |
Growth Inhibition Assay |
|
|
|
IC50=548.01 nM |
SANGER |
NCI-H1563 |
Growth Inhibition Assay |
|
|
|
IC50=556.49 nM |
SANGER |
HDLM-2 |
Growth Inhibition Assay |
|
|
|
IC50=568.59 nM |
SANGER |
NCI-H69 |
Growth Inhibition Assay |
|
|
|
IC50=568.8 nM |
SANGER |
NCI-SNU-5 |
Growth Inhibition Assay |
|
|
|
IC50=570.15 nM |
SANGER |
NCI-H1792 |
Growth Inhibition Assay |
|
|
|
IC50=572.43 nM |
SANGER |
NCI-H2141 |
Growth Inhibition Assay |
|
|
|
IC50=573.69 nM |
SANGER |
KMOE-2 |
Growth Inhibition Assay |
|
|
|
IC50=576.32 nM |
SANGER |
NCI-H1155 |
Growth Inhibition Assay |
|
|
|
IC50=579.87 nM |
SANGER |
LK-2 |
Growth Inhibition Assay |
|
|
|
IC50=581.07 nM |
SANGER |
HCC1187 |
Growth Inhibition Assay |
|
|
|
IC50=591.47 nM |
SANGER |
EGI-1 |
Growth Inhibition Assay |
|
|
|
IC50=598.27 nM |
SANGER |
NCI-H1623 |
Growth Inhibition Assay |
|
|
|
IC50=604.6 nM |
SANGER |
MN-60 |
Growth Inhibition Assay |
|
|
|
IC50=605.37 nM |
SANGER |
JAR |
Growth Inhibition Assay |
|
|
|
IC50=625.95 nM |
SANGER |
HCC1419 |
Growth Inhibition Assay |
|
|
|
IC50=631.74 nM |
SANGER |
LU-165 |
Growth Inhibition Assay |
|
|
|
IC50=639.4 nM |
SANGER |
TYK-nu |
Growth Inhibition Assay |
|
|
|
IC50=662.55 nM |
SANGER |
DG-75 |
Growth Inhibition Assay |
|
|
|
IC50=665.83 nM |
SANGER |
PFSK-1 |
Growth Inhibition Assay |
|
|
|
IC50=678.08 nM |
SANGER |
MKN7 |
Growth Inhibition Assay |
|
|
|
IC50=689.95 nM |
SANGER |
DMS-153 |
Growth Inhibition Assay |
|
|
|
IC50=698.15 nM |
SANGER |
HTC-C3 |
Growth Inhibition Assay |
|
|
|
IC50=703.94 nM |
SANGER |
GCIY |
Growth Inhibition Assay |
|
|
|
IC50=725.12 nM |
SANGER |
NCI-H1092 |
Growth Inhibition Assay |
|
|
|
IC50=737.95 nM |
SANGER |
EB-3 |
Growth Inhibition Assay |
|
|
|
IC50=771.02 nM |
SANGER |
CAL-120 |
Growth Inhibition Assay |
|
|
|
IC50=777.52 nM |
SANGER |
BT-474 |
Growth Inhibition Assay |
|
|
|
IC50=778.81 nM |
SANGER |
L-428 |
Growth Inhibition Assay |
|
|
|
IC50=790.9 nM |
SANGER |
Mo-T |
Growth Inhibition Assay |
|
|
|
IC50=804.65 nM |
SANGER |
CAL-72 |
Growth Inhibition Assay |
|
|
|
IC50=840.67 nM |
SANGER |
AsPC-1 |
Growth Inhibition Assay |
|
|
|
IC50=855.26 nM |
SANGER |
U-118-MG |
Growth Inhibition Assay |
|
|
|
IC50=856.34 nM |
SANGER |
GCT |
Growth Inhibition Assay |
|
|
|
IC50=861.48 nM |
SANGER |
EKVX |
Growth Inhibition Assay |
|
|
|
IC50=871.87 nM |
SANGER |
NCI-H1755 |
Growth Inhibition Assay |
|
|
|
IC50=873.52 nM |
SANGER |
Capan-2 |
Growth Inhibition Assay |
|
|
|
IC50=898.11 nM |
SANGER |
NCI-H1793 |
Growth Inhibition Assay |
|
|
|
IC50=900.87 nM |
SANGER |
PLC-PRF-5 |
Growth Inhibition Assay |
|
|
|
IC50=901.35 nM |
SANGER |
M14 |
Growth Inhibition Assay |
|
|
|
IC50=905.27 nM |
SANGER |
SK-MEL-24 |
Growth Inhibition Assay |
|
|
|
IC50=914.35 nM |
SANGER |
SK-MM-2 |
Growth Inhibition Assay |
|
|
|
IC50=942.3 nM |
SANGER |
PC-3 |
Growth Inhibition Assay |
|
|
|
IC50=957.22 nM |
SANGER |
EW-24 |
Growth Inhibition Assay |
|
|
|
IC50=970.4 nM |
SANGER |
MDA-MB-175-VII |
Growth Inhibition Assay |
|
|
|
IC50=971.53 nM |
SANGER |
NCI-H1581 |
Growth Inhibition Assay |
|
|
|
IC50=981.31 nM |
SANGER |
THP-1 |
Growth Inhibition Assay |
|
|
|
IC50=989.42 nM |
SANGER |
NCI-H1993 |
Growth Inhibition Assay |
|
|
|
IC50=1.00076 μM |
SANGER |
DOK |
Growth Inhibition Assay |
|
|
|
IC50=1.01762 μM |
SANGER |
KINGS-1 |
Growth Inhibition Assay |
|
|
|
IC50=1.019 μM |
SANGER |
YT |
Growth Inhibition Assay |
|
|
|
IC50=1.04568 μM |
SANGER |
TGBC1TKB |
Growth Inhibition Assay |
|
|
|
IC50=1.06036 μM |
SANGER |
TCCSUP |
Growth Inhibition Assay |
|
|
|
IC50=1.23083 μM |
SANGER |
BEN |
Growth Inhibition Assay |
|
|
|
IC50=1.23742 μM |
SANGER |
KARPAS-45 |
Growth Inhibition Assay |
|
|
|
IC50=1.26763 μM |
SANGER |
COLO-829 |
Growth Inhibition Assay |
|
|
|
IC50=1.2748 μM |
SANGER |
UACC-62 |
Growth Inhibition Assay |
|
|
|
IC50=1.32145 μM |
SANGER |
NCI-H446 |
Growth Inhibition Assay |
|
|
|
IC50=1.33771 μM |
SANGER |
RO82-W-1 |
Growth Inhibition Assay |
|
|
|
IC50=1.34337 μM |
SANGER |
NCI-H2452 |
Growth Inhibition Assay |
|
|
|
IC50=1.37129 μM |
SANGER |
RL |
Growth Inhibition Assay |
|
|
|
IC50=1.42066 μM |
SANGER |
NCI-H1522 |
Growth Inhibition Assay |
|
|
|
IC50=1.43159 μM |
SANGER |
TGW |
Growth Inhibition Assay |
|
|
|
IC50=1.45942 μM |
SANGER |
HT55 |
Growth Inhibition Assay |
|
|
|
IC50=1.47168 μM |
SANGER |
KARPAS-299 |
Growth Inhibition Assay |
|
|
|
IC50=1.47841 μM |
SANGER |
KY821 |
Growth Inhibition Assay |
|
|
|
IC50=1.49429 μM |
SANGER |
MDA-MB-231 |
Growth Inhibition Assay |
|
|
|
IC50=1.53055 μM |
SANGER |
NCI-H82 |
Growth Inhibition Assay |
|
|
|
IC50=1.57026 μM |
SANGER |
MDA-MB-134-VI |
Growth Inhibition Assay |
|
|
|
IC50=1.61711 μM |
SANGER |
PANC-08-13 |
Growth Inhibition Assay |
|
|
|
IC50=1.63084 μM |
SANGER |
D-542MG |
Growth Inhibition Assay |
|
|
|
IC50=1.65305 μM |
SANGER |
LC-1F |
Growth Inhibition Assay |
|
|
|
IC50=1.66203 μM |
SANGER |
KP-N-YN |
Growth Inhibition Assay |
|
|
|
IC50=1.66343 μM |
SANGER |
MFE-280 |
Growth Inhibition Assay |
|
|
|
IC50=1.66812 μM |
SANGER |
S-117 |
Growth Inhibition Assay |
|
|
|
IC50=1.70504 μM |
SANGER |
NCI-H1573 |
Growth Inhibition Assay |
|
|
|
IC50=1.71733 μM |
SANGER |
BT-20 |
Growth Inhibition Assay |
|
|
|
IC50=1.74068 μM |
SANGER |
NCI-H28 |
Growth Inhibition Assay |
|
|
|
IC50=1.74078 μM |
SANGER |
CaR-1 |
Growth Inhibition Assay |
|
|
|
IC50=1.78324 μM |
SANGER |
LN-405 |
Growth Inhibition Assay |
|
|
|
IC50=1.80143 μM |
SANGER |
RT4 |
Growth Inhibition Assay |
|
|
|
IC50=1.84417 μM |
SANGER |
NCI-H889 |
Growth Inhibition Assay |
|
|
|
IC50=1.93886 μM |
SANGER |
SW1463 |
Growth Inhibition Assay |
|
|
|
IC50=1.95701 μM |
SANGER |
SCLC-21H |
Growth Inhibition Assay |
|
|
|
IC50=2.00624 μM |
SANGER |
CP66-MEL |
Growth Inhibition Assay |
|
|
|
IC50=2.01767 μM |
SANGER |
Hs-578-T |
Growth Inhibition Assay |
|
|
|
IC50=2.01782 μM |
SANGER |
HCC70 |
Growth Inhibition Assay |
|
|
|
IC50=2.05463 μM |
SANGER |
SW1088 |
Growth Inhibition Assay |
|
|
|
IC50=2.06931 μM |
SANGER |
NB6 |
Growth Inhibition Assay |
|
|
|
IC50=2.185 μM |
SANGER |
KU-19-19 |
Growth Inhibition Assay |
|
|
|
IC50=2.26917 μM |
SANGER |
A704 |
Growth Inhibition Assay |
|
|
|
IC50=2.29135 μM |
SANGER |
EVSA-T |
Growth Inhibition Assay |
|
|
|
IC50=2.30089 μM |
SANGER |
HCT-15 |
Growth Inhibition Assay |
|
|
|
IC50=2.35466 μM |
SANGER |
HuO-3N1 |
Growth Inhibition Assay |
|
|
|
IC50=2.36583 μM |
SANGER |
GMS-10 |
Growth Inhibition Assay |
|
|
|
IC50=2.39738 μM |
SANGER |
TGBC24TKB |
Growth Inhibition Assay |
|
|
|
IC50=2.41429 μM |
SANGER |
C2BBe1 |
Growth Inhibition Assay |
|
|
|
IC50=2.51328 μM |
SANGER |
SK-N-DZ |
Growth Inhibition Assay |
|
|
|
IC50=2.56592 μM |
SANGER |
SK-N-AS |
Growth Inhibition Assay |
|
|
|
IC50=2.73015 μM |
SANGER |
T98G |
Growth Inhibition Assay |
|
|
|
IC50=2.80401 μM |
SANGER |
DMS-79 |
Growth Inhibition Assay |
|
|
|
IC50=2.90988 μM |
SANGER |
SNU-475 |
Growth Inhibition Assay |
|
|
|
IC50=2.92572 μM |
SANGER |
COLO-792 |
Growth Inhibition Assay |
|
|
|
IC50=3.0287 μM |
SANGER |
YAPC |
Growth Inhibition Assay |
|
|
|
IC50=3.32832 μM |
SANGER |
UACC-812 |
Growth Inhibition Assay |
|
|
|
IC50=3.33738 μM |
SANGER |
Mewo |
Growth Inhibition Assay |
|
|
|
IC50=3.46086 μM |
SANGER |
COLO-824 |
Growth Inhibition Assay |
|
|
|
IC50=3.57378 μM |
SANGER |
SCC-9 |
Growth Inhibition Assay |
|
|
|
IC50=3.91309 μM |
SANGER |
CP50-MEL-B |
Growth Inhibition Assay |
|
|
|
IC50=3.98703 μM |
SANGER |
NCI-H345 |
Growth Inhibition Assay |
|
|
|
IC50=4.01174 μM |
SANGER |
COR-L88 |
Growth Inhibition Assay |
|
|
|
IC50=4.3958 μM |
SANGER |
RCM-1 |
Growth Inhibition Assay |
|
|
|
IC50=4.49272 μM |
SANGER |
JVM-3 |
Growth Inhibition Assay |
|
|
|
IC50=4.60618 μM |
SANGER |
ECC4 |
Growth Inhibition Assay |
|
|
|
IC50=4.76541 μM |
SANGER |
MDA-MB-453 |
Growth Inhibition Assay |
|
|
|
IC50=4.85134 μM |
SANGER |
SK-N-FI |
Growth Inhibition Assay |
|
|
|
IC50=5.22877 μM |
SANGER |
D-502MG |
Growth Inhibition Assay |
|
|
|
IC50=5.24262 μM |
SANGER |
NCI-H2227 |
Growth Inhibition Assay |
|
|
|
IC50=5.36231 μM |
SANGER |
DMS-53 |
Growth Inhibition Assay |
|
|
|
IC50=6.17106 μM |
SANGER |
LB771-HNC |
Growth Inhibition Assay |
|
|
|
IC50=6.46806 μM |
SANGER |
BB49-HNC |
Growth Inhibition Assay |
|
|
|
IC50=7.41791 μM |
SANGER |
MDA-MB-415 |
Growth Inhibition Assay |
|
|
|
IC50=7.57303 μM |
SANGER |
TALL-1 |
Growth Inhibition Assay |
|
|
|
IC50=7.9688 μM |
SANGER |
HCC1395 |
Growth Inhibition Assay |
|
|
|
IC50=8.15122 μM |
SANGER |
EFE-184 |
Growth Inhibition Assay |
|
|
|
IC50=8.37216 μM |
SANGER |
EC-GI-10 |
Growth Inhibition Assay |
|
|
|
IC50=8.68686 μM |
SANGER |
TT |
Growth Inhibition Assay |
|
|
|
IC50=9.06966 μM |
SANGER |
U-2-OS |
Growth Inhibition Assay |
|
|
|
IC50=9.81393 μM |
SANGER |
SHP-77 |
Growth Inhibition Assay |
|
|
|
IC50=9.9029 μM |
SANGER |
HCC1143 |
Growth Inhibition Assay |
|
|
|
IC50=10.4797 μM |
SANGER |
A498 |
Growth Inhibition Assay |
|
|
|
IC50=18.2976 μM |
SANGER |
LS-513 |
Growth Inhibition Assay |
|
|
|
IC50=18.6093 μM |
SANGER |
K052 |
Growth Inhibition Assay |
|
|
|
IC50=21.4418 μM |
SANGER |
SiHa |
Growth Inhibition Assay |
|
|
|
IC50=23.3371 μM |
SANGER |
RCC10RGB |
Growth Inhibition Assay |
|
|
|
IC50=30.0611 μM |
SANGER |
NCI-SNU-16 |
Growth Inhibition Assay |
|
|
|
IC50=31.1836 μM |
SANGER |
SNU-C1 |
Growth Inhibition Assay |
|
|
|
IC50=32.4175 μM |
SANGER |
C32 |
Growth Inhibition Assay |
|
|
|
IC50=32.872 μM |
SANGER |
SW684 |
Growth Inhibition Assay |
|
|
|
IC50=34.1561 μM |
SANGER |
SK-MEL-28 |
Growth Inhibition Assay |
|
|
|
IC50=35.5377 μM |
SANGER |
SK-MEL-1 |
Growth Inhibition Assay |
|
|
|
IC50=36.7547 μM |
SANGER |
NCI-H720 |
Growth Inhibition Assay |
|
|
|
IC50=41.9726 μM |
SANGER |
P31-FUJ |
Growth Inhibition Assay |
|
|
|
IC50=44.3284 μM |
SANGER |
NCI-H524 |
Growth Inhibition Assay |
|
|
|
IC50=48.8248 μM |
SANGER |